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“This is the true joy in life, the being used for a purpose recognized by yourself as a mighty one,  
the being thoroughly worn out before you are thrown on the scrap heap,  
the being a force of Nature instead of a feverish selfish little clod of ailments and grievances 
complaining that the world will not devote itself to making you happy.” 
 
George Bernard Shaw 
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1  Introduction 
 
1.1  Folk Medicine 
Austrian traditional folk medicine represents a valuable source of information in the 
finding of new active principles. Medicinal plants are used since decades for the 
treatment of every form of illness, but in most cases their active constituents and the 
relative mode of action are still unknown. As nowadays about 60% of the new 
pharmaceutics derive from molecular structures of natural origin, natural products in 
general play a dominant role in the development of drugs for the treatment of human 
diseases (Newman and Cragg, 2007).  
Folk medicine exists since ever, as humans always tried to find ways of lessening 
pain and to remedy any form of mental or physical problems. In 18th and 19th century 
medical services were too expensive or too far away for most people, that’s why 
they usually relied on the knowledge of non-professional practitioners to treat their 
illnesses.  
Since the starting point of this study was represented by the popular medicine, only 
traditionally used plants were selected on the basis of information that had been 
passed on from generation to generation in Austria. These type of data are collected 
in the “Volksmed-Database”, which was created by means of interviews with 1857 
persons from 1983 to 1995. They were questioned about their customs in the use of 
medicinal plants, in order to collect the current traditional knowledge.  
The database includes exact botanical descriptions, information about the part of the 
plant used, indications, preparation and application method, as well as number of 
citations. Of about 100 plant species traditionally used in Austria against several 
diseases, where Hypericum perforatum L. resulted as the most often used, the 
therapeutic properties of the most part have still to be scientifically proven (Gerlach 
et al, 2006; Benedek, 2007). 
An ointment from Symphytum officinale roots, for example, whose anti-inflammatory 
properties are described in the Austrian popular medicine, was found to be at least 
so active as a Diclofenac ointment in the treatment of acute unilateral ankle sprain 
(Predel et al, 2005).  
The antibacterial activity of Leontopodium alpinum, which is traditionally used as a 
tea or cooked in milk to treat dysentery, was confirmed in vitro against various 
strains of Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, 
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Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes 
(Dobner et al, 2003). 
 
 
1.2  Inflammation 
Inflammation (from the Latin - inflammare: to set on fire) is a common denominator 
of a variety of diseases including arthritis, atherosclerosis, allergies and cancer. 
Therefore, natural compounds with anti-inflammatory properties represent an 
important group of therapeutics (Dvorak et al, 2006). Whereas inflammation 
pathways and relative inducers are mostly known, there is less information about the 
inhibitors of these processes. The main goal of this thesis was the identification of 
substances from Austrian medicinal plants, possibly with new anti-inflammatory 
mechanisms of action, which could potentially find therapeutic application. 
The inflammatory response is characterized by coordinate activation of various 
signaling pathways, that regulate expression of both pro- and anti-inflammatory 
mediators in resident tissue cells and leukocytes recruited from the blood 
(Lawrence, 2009).  
In general, inflammation represents a protective response of the organism against 
harmful physical, chemical or biological stimuli, aimed to the elimination of the initial 
cause of cellular and tissue damage. It consists of a sequence of events, which 
determine an intense vascular reaction characterized by the following five cardinal 
signs: calor (heat), tumor (edema), rubor (redness), dolor (pain) and functio laesa 
(loss of function). The first four signs were described for the first time over 2000 
years ago by the Roman encyclopedist and healer Aulus Cornelius Celsus, while the 
sign functio laesa was added later by Galen (Sobolewski et al, 2010). Heat is 
intended as an increased tissue temperature, consequence of the vasodilation; 
edema is caused by migration of blood cells to the damaged tissue; redness is due 
to increased vascular activity in the involved area; pain is caused by stimulation of 
peripheral nociceptors by mediators such as bradykinin, while the loss of function is 
the possible consequence of the previous events. 
A controlled inflammatory process is beneficial, as it provides protection and repair 
in case of several threats, but it can also become detrimental in case of 
dysregulation causing, for instance, septic shock. The elimination of the infectious 
agents, followed by a resolution and repair phase (mediated by tissue-resident and 
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recruited macrophages), represents the goal of the successful acute inflammatory 
response. Of relevant importance in the transition from inflammation to resolution is 
the switch from pro-inflammatory prostaglandins to anti-inflammatory lipoxins, which 
promote the recruitment of monocytes, responsible for dead cells removing and 
tissue remodelling, instead of neutrophils (Medzhitov, 2008). 
At a basic level, the process can be classified in acute and chronic. Acute 
inflammation is the fast response to injurious agents, which consists in the delivery 
of leukocytes and plasma proteins to the damaged site. The transmigration is 
consented by vasodilatation and consequent increased permeability, and promoted 
by cell adhesion molecules like E-selectin, P-selectin, ICAM (intracellular adhesion 
molecule) and VCAM (vascular cell adhesion molecule). Subsequently, the 
pathogens are engulfed and digested by macrophages (phagocytosis), which also 
stimulate lymphocytes to play their role. Chronic inflammation can be represented 
by persistent acute inflammation or a type of autoimmune reaction. In this case, 
permanent inflammation and tissue healing take place simultaneously. Examples of 
chronic inflammation are asthma, rheumatoid arthritis and multiple sclerosis. 
In summary, inflammation is a complex phenomenon which involves several cell 
types in different pathways. On the one hand the acute inflammatory response 
represents a vital defense system of the organism, on the other hand chronic 
inflammation can lead to pathologies such as cancer, diabetes, Alzheimer’s disease 
and neuropathic pain states (Sobolewski et al, 2010). 
 
 
1.3  Selection of the Drugs 
Since inflammation represents the fulcrum of this study, all indications that can be 
related to it were used as filter options in the Volksmed-Database. From the 
numerous hits (9190 citations) the most promising 226 drugs were chosen due to 
number of citations. After a literature research, 35 drugs of 31 plant species from 17 
families were selected to be investigated, as they were not or poorly studied so far. 
As Sambucus nigra (flowers and fruits) resulted the most cited species, it has been 
considered interesting to also include the related taxon Sambucus ebulus, with the 
aim of getting a comprehensive picture of their relationship with each other. An 
overview of the plant species with more than 10 citations in the Volksmed-Database, 
intended as the number of mentions occurred in the interviews, is shown in Fig. 1. 
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Figure 1:  Plant species with more than 10 citations in the Volksmed-Database 
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In a first step, polar and non polar extracts of all selected drugs were generated and 
pharmacological screened in vitro on different targets focusing on anti-inflammatory 
activities. 
In a general ranking (see Table 6, pag. 30), the herbs of the Lamiaceae Betonica 
officinalis and Glechoma hederacea were determined as promising candidates and 
selected to be subjected to a bioactivity guided fractionation, in order to identify and 
pharmacologically evaluate their active constituents. 
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1.4  Betonica officinalis L. 
Betonica officinalis L. (syn: Stachys officinalis L.), commonly known as Wood 
betony, is a perennial herb found growing wild in Europe, North Africa and western 
Asia (Fig. 2). The stems, slender and square, have a height from 15 to 40 cm, while 
the stalked basal leaves are oval. The dense and tubular reddish-purple magenta 
flowers have five lobes, from which the lower three ones are bent back. A persistent 
smooth five-toothed calyx contains the fruit, which consists of four small nutlets 
(Tobyn et al, 2010). 
Wood betony was once the sovereign remedy for all maladies of the head (Grieve, 
1971). The old italian proverb "sell your coat and buy betony” indicates the versatility 
of this plant as a remedy for several diseases. In Austrian folk medicine, the aerial 
parts of the plant are mainly prescribed as an aqueous infusion against inflammatory 
disorders of the upper respiratory system and as an ointment for the treatment of 
skin lesions (Gerlach et al, 2006).  
Iridoid glycosides, flavonoids and phenylethanoid glycosides (Jeker et al, 1989; 
Kobzar and Nikonov, 1986; Miyase et al, 1996) were already identified in the aerial 
parts of the plant. They were also found to contain 0.5% of essential oil, with a 
mixture of isocaryophyllene and β-caryophyllene (22.9%) as its principal component 
(Chalchat et al, 2001).  
Glycosides from Betonica officinalis were found to possess hypotensive activity 
(Zinchenko et al, 1962), while antioxidant activity was observed by total flavonoids 
contained in the leaves, more than in the roots (Hajdari et al, 2010). The plant was 
also found to possess strong antioxidant activity in phosphomolybdenum and lipid 
peroxidation assays (Matkowski and Piotrowska, 2006), as well as in DPPH and 
FRAP experiments (Hajdari et al, 2010).  
Potent in vivo anti-inflammatory activity was determined in the related species 
Stachys inflata using carrageenan-induced paw edema and formalin tests (Maleki et 
al, 2001). 
The aerial parts of the plant at flowering stage (5 kg) were field-collected in June 
2008 in Neustift am Walde (Vienna, Austria), and dried at room temperature. 
Voucher specimens (Bet-hb-08_1) are deposited at the Department of 
Pharmacognosy, University of Vienna. 
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Figure 2:  Betonica officinalis L. 
(source: Botanical.com) 
 
 
 
 
1.5  Glechoma hederacea L. 
Commonly known as Ground ivy, Glechoma hederacea L. (Fig. 3) is a perennial 
hairy herb with unbranched square stems, which bear numerous, kidney-shaped 
dark green leaves, stalked and opposite to one another, and characterized by 
rounded indentations on the margins. Purplish blue flowers with small white spots 
are placed in the axils of the upper leaves (Grieve, 1971). 
Common to Europe and the United States, the plant is found growing in shady 
places, waste grounds, dry ditches and on the sides of moist meadows (Felter and 
Lloyd, 2003). According to Green (1832), the Ground ivy expels the plants which 
grow near it, impoverishing pastures. In Austria, the aerial parts of the plant are 
traditionally used mainly in the form of tea, against cold and influenza, 
gastrointestinal disorders, respiratory and urinary tract inflammations. The most 
recurrent indication, however, is for the treatment of liver and gall bladder diseases 
(Gerlach et al, 2006).  
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Flavonoids, triterpenoids, sesquiterpenoids, alkaloids, glycosides and 
hydroxycinnamic acids have already been isolated from the aerial parts of the plant 
(Zieba, 1973; Milovanovic et al, 1995; Kumarasamy et al, 2003; Kikuchi et al, 2008; 
Yamauchi et al, 2007; Vavilova et al, 1988; Stahl et al, 1972). An aqueous extract 
was found to inhibit the production of nitric oxide in IFN-γ- and LPS-stimulated 
mouse peritoneal macrophages, through inhibition of iNOS expression (An et al, 
2006), while anti-hypertensive activity, determined by higher sodium excretion rate, 
was observed in spontaneously hypertensive rats (Watanabe et al, 2007). 
The dried aerial parts of the plant (2 kg) were obtained from the drug store Kottas 
Pharma GmbH (Vienna, Austria; Batch Nr.: KLA70586). A second sample of the 
plant, field-collected in Laab im Walde (Austria), was chromatographically and 
pharmacologically compared with the first one. Voucher specimens of the two plant 
samples (Gle-hb-08_1 and Gle-hb-08_2, respectively) are deposited at the 
Department of Pharmacognosy, University of Vienna. 
 
Figure 3:  Glechoma hederacea L. 
(source: Flora batava by Jan Kops, Herman Christiaan, et al.) 
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1.6  Chlorophyll and Polyphenols in Plant Extracts 
Chlorophyll can represent the major part of nonpolar plant extracts. Besides the 
possible interference in the in vitro test systems, its removal results in a significantly 
increased relative concentration of the active compounds. Polyphenols, on the other 
hand, can form tight complexes with metal ions, proteins and polysaccharides 
(Potterat and Hamburger, 2006), leading to false positive or false negative results in 
cell-based assays. Their removal, furthermore, should result in the enrichment of the 
compounds of interest as well. Thus, nonpolar and polar extracts were purified from 
chlorophyll and polyphenols, respectively, with the removal techniques described in 
chapters 2.6 and 2.7. 
A comparison between three different chlorophyll and polyphenols removal methods 
was also carried out, in order to find the most effective way of purification and to 
examine whether such ubiquitous plant constituents lead to any problems in the 
used cell-based anti-inflammatory tests. Different methodologies aimed to their 
removal were applied, and their selectivity for the target molecules was evaluated by 
chromatographic techniques. Extracts from the herbs of Malva sp. and Glechoma 
hederacea were used for this purpose, and the possible influence of the pure 
compounds chlorophyll A, chlorophyll B, tannic acid, epicatechin gallate, and 
rosmarinic acid (Fig. 4), which is known to be present in Glechoma hederacea 
(Okuda et al, 1986), was additionally evaluated in the same in vitro assays. 
 
Figure 4:  Chemical formulae of the tested ubiquitous plant components  
(A: chlorophyll A; B: chlorophyll B; C: tannic acid; D: epicatechin gallate; E: rosmarinic acid) 
 
  A 
  B     
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The phytochemical work of these specific investigations was performed together 
with ao. Univ.-Prof. Dr. Judith M. Rollinger, Institute of Pharmacy, University of 
Innsbruck; Univ.-Prof. Dr. Rudolf Bauer, Institute of Pharmaceutical Sciences, 
University of Graz and Mag. Sylvia Vogl, Department of Pharmacognosy, University 
of Vienna. The pharmacological tests were carried out in cooperation with Judit 
Mihaly-Bison and Priv.-Doz. Mag. Dr. Valery Bochkov, Department of Vascular 
Biology and Thrombosis Research, Medical University of Vienna and with Dr. 
Atanas G. Atanasov, Department of Pharmacognosy, University of Vienna. 
 
 
1.7  Biological Targets 
The cell-based evaluation of compounds focusing on anti-inflammatory activities can 
be carried out on several biological targets. Our cooperation with the Medical 
University of Vienna, as well as with the pharmacological group “Molecular Targets” 
of the Department of Pharmacognosy, University of Vienna, gave us the opportunity 
to perform the bioactivity guided fractionation using five different in vitro assays. The 
ability of the candidates to activate the peroxisome proliferator-activated receptors   
–α and –γ, to inhibit the TNF-α-induced NF-κB activation, as well as the TNF-α- and 
LPS-induced E-selectin and IL-8 expression should result in an overview of their 
potential as anti-inflammatory agents. 
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1.7.1  Peroxisome Proliferator-Activated Receptors (PPARs) 
PPARs are members of the nuclear-hormone-receptor superfamily and are able to 
transduce a wide variety of signals, including inflammatory events, into a defined 
and ordered set of cellular responses at the level of gene transcription. So far, three 
PPAR isoforms – PPAR-α, PPAR-β/δ and PPAR-γ – have been identified and 
cloned (Daynes and Jones, 2002). The receptors PPAR-α and –γ, in particular, are 
also expressed in endothelial cells and vascular smooth muscle cells, where they 
are considered to play an important role in the regulation of inflammatory responses 
(Blaschke et al, 2006).  
The ability of the PPARs to regulate inflammatory responses depends on their 
transactivation and transrepression capacities. Most of their anti-inflammatory 
properties arise through their ability to antagonize the nuclear factor κB (NF-κB) and 
AP1 signaling pathways (Fig. 5). In this way, the PPARs repress the expression of 
several genes that are involved in the inflammatory response, such as cytokines, 
cell-adhesion molecules and other pro-inflammatory signal mediators. PPAR-α has 
also been reported to control duration and magnitude of the inflammatory response, 
through the expression of genes encoding proteins that are involved in the 
catabolism of pro-inflammatory lipid mediators (Daynes and Jones, 2002). The aim 
was therefore to discover potent activators of PPAR-α and -γ by utilizing HEK293 
cell-based luciferase reporter gene assays. 
 
Figure 5:  Role of PPARs in regulation of inflammatory responses 
(source: Daynes and Jones, 2002) 
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1.7.2  Nuclear Factor κB (NF-κB) 
The one of the nuclear factor κB has long been considered a prototypical 
proinflammatory signaling pathway, as it results in the expression of 
proinflammatory genes including cytokines, chemokines, and adhesion molecules 
(Lawrence, 2009). Therefore, much attention has focused on the development of 
anti-inflammatory drugs targeting on it (Karin et al, 2004).  
In physiological conditions, the heterodimer NF-κB (p50/p65) is found in the 
cytoplasm of endothelial cells, inactivated by the protein IκB-α. The local release of 
cytokines like TNF-α by damaged cells activates the IκB-α kinase, which 
phosphorylates IκB-α. This results in the release of NF-κB, which translocates to the 
nucleus, where the subunit p65 activates the transcription of pro-inflammatory 
genes. Among others, the transcription of the cell adhesion molecule E-selectin and 
the chemokine IL-8 is activated (Fig. 6).  
Pharmaceuticals such as aspirin or sodium salicylate are able to inhibit the NF-κB 
activation blocking IκB-α phosphorylation and degradation (Pierce et al, 1996). 
Lawrence et al. (2001) demonstrated the involvement of NF-κB also in the resolution 
of acute inflammation using pharmacological inhibitors. They confirmed the 
expected role of NF-κB in pro-inflammatory gene induction, but they also showed its 
role in the expression of anti-inflammatory genes and induction of leukocyte 
apoptosis during the resolution of inflammation. Inhibition of NF-κB during the 
resolution phase prolonged inflammatory response and inhibited apoptosis, in 
conflict with the generally accepted view that NF-κB was anti-apoptotic in 
inflammatory cells.  
As the NF-κB pathway represents a valuable target for testing anti-inflammatory 
candidates, a HEK293 cell-based luciferase reporter gene assay (specific for NF-κB) 
was also selected for the investigations of this thesis. 
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Figure 6:  Role of NF-kB in the inflammation process 
(source: Mutschler et al, Arzneimittelwirkungen) 
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1.7.3  E-selectin and Interleukin-8 (IL-8) 
The downregulation of stimulated E-selectin and IL-8 in endothelial cells represents 
also an important tool in the field of inflammation, particularly as their expression 
can be correlated with the NF-κB activation. Moreover, the possibility to stimulate 
the endothelium with two inflammatory stimuli (TNF-α and LPS), having different 
chemical nature and interacting with different receptors, enhances the reliance of 
the test system. These compounds are known to play a role in distinct but partially 
overlapping signaling pathways in the inflammation process.  
In human umbilical vein endothelial cells (HUVEC), which were selected for our 
investigations, the expression of E-selectin can be induced, for instance, by 
lipopolysaccharide (LPS) on the transcriptional level and its maximal levels are 
expressed within 4 hours after stimulation at the cell surface (Kosonen et al, 2000; 
Bevilacqua et al, 1987; Vestweber and Blanks, 1999). 
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Previously known as endothelial leukocyte adhesion molecule-1 (ELAM-1),            
E-selectin is expressed exclusively in endothelial cells as consequence of IL-1, TNF-
α, or LPS stimulation (De Rose et al, 1998; Bevilacqua et al, 1989). Precisely, it 
promotes the “rolling step”, namely the reversible adhesion of leukocytes to the 
endothelium, which then fix themselves to the surface of the vessel in the “sticking 
step”. Subsequently, the leukocytes migrate through the vessel to the site of injury 
or infection (diapedesis) via a gradient of chemotactic factors (Frenette and Wagner, 
1997; Verbeuren et al, 2009).  
Interleukin-8 is a potent chemotactic factor with a key role in host defense 
mechanisms, which release is consequence of inflammatory signals from a variety 
of cells such as neutrophils, smooth muscle cells and endothelial cells (Yuan et al, 
2009; Mukaida et al, 1998). In the inflammation process, this chemokine is 
responsible for the leukocyte recruitment to the endothelium. Secreted as 
consequence of monocytes and macrophages activation, IL-8 determines the 
directional migration of neutrophils, basophils and T lymphocytes (Brat et al, 2005; 
Baggiolini et al, 1989; Rossi and Zlotnik, 2000). 
 
 
1.8  Objective 
As the pharmacologically active principles of most medicinal plants are still 
unknown, the aim of this thesis was to find new anti-inflammatory modes of action 
and / or new active natural compounds in Austrian traditionally used plant species. 
Considering that medicinal plants are often prescribed in the form of tea, their active 
principles represent only a minor part of an aqueous extract. Therefore, it would be 
of great interest to isolate and identify these constituents, in order to evaluate their 
biological properties in the form of pure compounds.  
The possible influence of ubiquitous plant constituents such as chlorophyll and 
phenolic compounds in the employed in vitro assays, as well as the choice of 
adequate techniques to remove them, represented also an important point of this 
thesis. 
The bio-evaluation of plant materials used in traditional medicine is widely 
attempted. Furthermore, most studies focus solely on the identification of 
constituents or assessment of single biologic activities of the identified compounds, 
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eventually overlooking multifaceted regulatory mechanisms reflecting the complexity 
of their composition.  
Of the several possible in vitro anti-inflammatory targets, the peroxisome 
proliferator-activated receptors α and γ, the nuclear factor κB, the cell adhesion 
molecule E-selectin and the cytokine interleukin-8 were chosen in this study for the 
investigation of the selected plants. 
Leitmotif of the thesis was definitely a bioactivity guided fractionation, which led from 
the selected plant materials to the isolation and testing of promising anti-
inflammatory substances (Fig. 7). 
 
 
Figure 7:  Overview of the investigation process from the selection of the plant species  
to the testing of pure compounds isolated thereof 
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2  Material and Methods 
 
2.1  Plant Material 
15 plant samples were field-collected from 2008 to 2009 together with Mag. Sylvia 
Vogl in different locations in Austria, while further 20 drugs were obtained from drug 
stores. The plant material was authenticated by Prof. Johannes Saukel and dried at 
room temperature. Voucher specimens thereof are deposited at the Department of 
Pharmacognosy, University of Vienna. 
As the extractions should be followed by several purification and fractionation steps, 
it is of relevant importance to dispose of large amounts of homogenous plant 
material. Therefore, the finding of adequate quantities of wild plant samples and 
their identification represented a crucial initial phase of this study. At least 2 kg of 
each plant species were collected from the wild or purchased from the companies 
Alfred Richter GmbH, Kottas Pharma GmbH and Alfred Galke GmbH.  
After the authentication, the plant material was dried at room temperature and finely 
grinded (particle size: 0.75 mm) before the extraction. The investigated plant 
species ordered by family are listed in Table 1. 
 
Table 1:  Investigated drugs and their sources 
Family Species Plant Part Plant Source 
Adoxaceae Sambucus ebulus Fruits Laab im Walde / Wolfsgraben 
Adoxaceae Sambucus nigra Flowers Alfred Richter GmbH 
Adoxaceae Sambucus nigra Fruits Kottas Pharma GmbH 
Asteraceae Bellis perennis Flowers Alfred Galke GmbH 
Asteraceae Petasites hybridus Leaves Hoher Student 
Asteraceae Tussilago farfara Leaves Alfred Richter GmbH 
Berberidaceae Berberis vulgaris Fruits Kottas Pharma GmbH 
Betulaceae Alnus viridis Leaves Lungau 
Boraginaceae Symphytum officinale Stem Neusiedlersee region 
Boraginaceae Symphytum officinale Leaves Neusiedlersee region 
Boraginaceae Symphytum officinale Roots Kottas Pharma GmbH 
Brassicaceae Capsella bursa-pastoris Herb Kottas Pharma GmbH 
Chenopodiaceae Beta vulgaris Roots Alfred Galke GmbH 
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Elaeagnaceae Hippophae rhamnoides Fruits Alfred Galke GmbH 
Equisetaceae Equisetum arvense Herb Alfred Richter GmbH 
Equisetaceae Equisetum palustre Herb Neusiedlersee region 
Ericaceae Calluna vulgaris Herb Kottas Pharma GmbH 
Ericaceae Vaccinium myrtillus Fruits Alfred Richter GmbH 
Ericaceae Vaccinum vitis-idea Fruits Hochwechsel 
Gentianaceae Gentiana punctata Leaves Pollertal / Kärnten 
Gentianaceae Gentiana punctata Roots Pollertal / Kärnten 
Hypericaceae Hypericum maculata Herb Katschberg 
Lamiaceae Ajuga genevensis Herb Weinviertel / Lahner 
Lamiaceae Ajuga reptans Herb Laab im Walde / Wolfsgraben 
Lamiaceae Betonica officinalis Herb Neustift am Walde 
Lamiaceae Glechoma hederacea Herb Kottas Pharma GmbH 
Lamiaceae Majorana hortensis Herb Alfred Richter GmbH 
Lamiaceae Melissa officinalis Leaves Alfred Galke GmbH 
Lamiaceae Origanum vulgare Herb Alfred Richter GmbH 
Lamiaceae Prunella vulgaris Herb Neustift am Walde 
Lamiaceae Salvia officinalis Leaves Alfred Richter GmbH 
Linum Linum usitatissimum Seeds Alfred Richter GmbH 
Lycopodiaceae Lycopodium sp. Herb Kottas Pharma GmbH 
Poaceae Agropyron repens Rhizomes Kottas Pharma GmbH 
Piceaceae Picea abies Shoot tips Wechsel / Mariensee 
 
 
2.2  Reference Compounds 
The identification of the isolated substances was performed also by comparison with 
reference pure compounds, which sources and purity factors are listed in Table 2. 
 
Table 2:  Purity factors and origin of the reference compounds 
Reference compound Purity Company 
Acacetin 98% Phytolab, Hamburg, Germany 
Apigenin 98% Phytolab, Hamburg, Germany 
2-benzoxazolinone 98% Sigma Aldrich, Steinheim, Germany 
Chlorophyll A 95% Fluka Chemical Corp., Ronkonkoma, NY, USA 
Chlorophyll B 95% Fluka Chemical Corp., Ronkonkoma, NY, USA 
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Epicatechin gallate 98% Sigma Aldrich, Steinheim, Germany 
Eupatorin 97% ABCR, Karlsruhe, Germany 
Harpagide 95% Phytolab, Hamburg, Germany 
Harpagoside 95% Phytolab, Hamburg, Germany 
Rosmarinic acid 98% Extrasynthese, Genay, France 
Tannic acid - Fluka Chemical Corp., Ronkonkoma, NY, USA 
 
 
2.3  In Silico Screening 
Virtual screening is a well-established tool for predicting biological activities of small 
organic molecules and selecting promising compounds for biological testing (Reddy 
et al, 2007; Rester, 2008; Kirchmair et al, 2008; Schneider, 2010; Markt et al, 2011). 
An extensive literature survey resulted in a list of compounds, known to be present 
in the selected plant species, which were converted into mol-files for further 
processing in the in silico screening on two different molecular targets. In order to 
predict their biological effects, the huge number of 1713 structures was virtual 
screened for their potential to activate the PPAR-γ as well as the Farnesoid X 
receptor (FXR), whose signaling mechanisms are known to be involved in anti-
inflammatory responses. FXR is also a nuclear receptor, particularly expressed in 
the liver, which plays a role in inflammation as a negative modulator in the NF-κB 
pathway. Its activation, followed by the translocation into the nucleus, was found to 
inhibit the expression of inflammatory mediators in response to the hepatic NF-κB 
activation in vitro (Wang et al, 2008). 
Compounds which were identified in the selected plants Betonica officinalis and 
Glechoma hederacea (see chapter 3.2.2) were additionally tested in a second time 
for their ability to bind the enzymes 5-lipoxygenase (5-LOX) and IkappaB kinase-2 
(IKK-2), which are responsible for the synthesis of proinflammatory leukotrienes and 
for the NF-κB activation, respectively. 
All molecules were submitted to conformational model generation using 
DiscoveryStudio 2.5. A maximum of 250 conformers with an energy maximum of 20 
kcal above the minimum was calculated in “fast” mode. The parallel profiling was 
performed using the “rigid fitting” option. 
These experiments were carried out in cooperation with Dr. Daniela Schuster, 
Institute of Pharmacy, Computer-Aided Molecular Design Group, University of 
Innsbruck. 
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2.4  Extraction Techniques Comparison 
Before starting the experimental work, some preliminary tests were performed, in 
order to compare the efficiency of different extraction methods, using the herb of 
Calluna vulgaris as model drug. The plant material (5.0 g) was first extracted three 
times with dichloromethane as solvent in an ultrasonic bath, for 15 minutes at room 
temperature. The yield was then compared with two extraction methods using an 
Accelerated Solvent Extractor ASE200 (Dionex Corp., Sunnyvale, CA, USA). 
Compared with other extraction techniques, the ASE generates results in a fraction 
of the time. Increased temperature accelerates the extraction kinetics, while 
elevated pressure by means of nitrogen keeps the solvent below its boiling point. In 
addition to speed, ASE offers a lower cost per sample by reducing solvent 
consumption up to 90%.  
This automatized extractor allows basically to perform extractions in one or more 
cycles, intended as the number of times to perform the static heating and flushing 
steps. When more than one cycle is programmed, the flush volume is divided 
among the cycles.  
The first method with the ASE consisted in an extraction with 3 cycles, while in the 
second one the plant material was extracted three times using one cycle. The 
results showed that the method where the plant material was extracted three times 
with one cycle was the most efficient (Fig. 8). Therefore, this method was applied for 
the extraction of all other drugs. 
 
 
Figure 8:  Extraction techniques comparison 
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2.5  Extraction 
In a first time, amounts between 4 and 8 g of each drug were extracted, depending 
on the bulkiness of the plant material and on the necessity to mix it with 
diatomaceous earth, which is essential in the case of the fruits, acting as a 
dispersant and drying agent. As the used 33 ml extraction cells did not allow the 
processing of larger drug amounts, a second extraction was necessary in some 
cases. 
In order to cover a wide range of polarity, the same plant material was extracted first 
with dichloromethane (DCM) and, after drying via nitrogen, with methanol. Both 
solvents were of analytical grade and purchased from Merck (Darmstadt, Germany).  
The employed Dionex ASE200, which was equipped with 33 ml stainless steel 
extraction cells and 60 ml glass collection bottles, was programmed with the 
following conditions: 3 extraction cycles (3 times 1 cycle), 5 min heat-up time, 2 min 
static time, 10% flush volume, 60 sec nitrogen purge, 40 °C oven temperature and 
150 bar pressure. The extracts were taken to dryness under reduced pressure, 
weighed and prepared for further processing.  
The extraction yields (w/w) of the selected 35 drugs are listed in Table 3. 
 
Table 3:  Extraction yields (w/w) of the 35 investigated drugs 
Plant species Plant part 
DCM extract 
(Yield %) 
MeOH extract 
(Yield %) 
Agropyron repens Rhizomes 1.3 27.0 
Ajuga genevensis Herb 3.3 24.8 
Ajuga reptans Herb 2.7 22.9 
Alnus viridis Leaves 9.4 28.0 
Bellis perennis Flowers 4.1 15.8 
Berberis vulgaris Fruits 0.2 44.8 
Beta vulgaris Roots 0.5 14.6 
Betonica officinalis Herb 1.6 15.4 
Calluna vulgaris Herb 8.7 27.4 
Capsella bursa-pastoris Herb 1.8 17.8 
Equisetum arvense Herb 6.5 14.6 
Equisetum palustre Herb 2.6 6.8 
Gentiana punctata Leaves 5.7 46.5 
Gentiana punctata Roots 4.2 44.2 
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Glechoma hederacea Herb 2.5 7.7 
Hippophae rhamnoides Fruits 18.3 23.4 
Hypericum maculata Herb 27.0 34.6 
Linum usitatissimum Seeds 75.7 11.2 
Lycopodium sp. Herb 1.7 6.6 
Majorana hortensis Herb 11.6 30.5 
Melissa officinalis Leaves 4.6 6.6 
Origanum vulgare Herb 10.1 27.9 
Petasites hybridus Leaves 4.0 17.6 
Picea abies Shoot tips 4.0 37.6 
Prunella vulgaris Herb 2.5 14.3 
Salvia officinalis Leaves 24.3 9.2 
Sambucus ebulus Fruits 1.3 84.8 
Sambucus nigra Flowers 5.9 18.9 
Sambucus nigra Fruits 0.7 16.3 
Symphytum officinale Leaves 3.2 10.8 
Symphytum officinale Roots 0.7 5.9 
Symphytum officinale Stems 4.2 14.4 
Tussilago farfara Leaves 9.1 18.6 
Vaccinium myrtillus Fruits 10.7 84.3 
Vaccinum vitis-idea Fruits 8.4 57.9 
 
 
2.6  Chlorophyll Removal 
All nonpolar extracts with a presumable significant content of chlorophyll (herbs and 
leaves) were subjected to a purification process, which was based on a liquid-liquid 
partition between DCM and a mixture of MeOH/H2O (Fig. 9). 
Dry extracts were redissolved in a defined volume of DCM (6.67 mg/ml), the same 
amount of MeOH/H2O 1:1 was added and the two obtained phases were shortly 
shaked. As the DCM phase was completely removed under reduced pressure, the 
most nonpolar constituents, mainly chlorophyll, precipitated in the MeOH/H2O phase 
and could be filtered off.  
The aqueous phase was finally taken to dryness under reduced pressure, yielding 
the chlorophyll free DCM extract (wCh). 
 
 
 20
Material and Methods 
 
 
Figure 9:  Scheme of the chlorophyll removal process 
 
 
 
2.7  Polyphenols Removal 
Polyphenols were removed from the polar extracts, according to Wall et al. (1996). 
The purification process is based on liquid-liquid partitions between chloroform and 
mixtures of MeOH/H2O (Fig. 10). 
Dry MeOH extracts were first redissolved in a mixture of MeOH/H2O (9:1) and 
defatted by partition with hexane. Subsequently, the aqueous phase whose polarity 
was increased by addition of water (MeOH/H2O 3:1), was partitioned with chloroform 
and the consequent chloroform extract was further washed with a 1% NaCl solution, 
generating the phenolic free CHCl3 extract (wP). 
 
Figure 10:  Scheme of the polyphenols removal process 
MeOH extract
add H2O, partition with CHCl3
Aqueous extract
Dissolve in MeOH-H2O (9:1)
wash with 1% NaCl
Defat with hexane
Hexane extract Residue
CHCl3 extract
Phenolic free CHCl3 extract
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2.8  Solid Phase Extraction (SPE) 
Despite the extraction with two different solvents and the described purification 
processes, crude extracts might contain a large number of constituents. Therefore, a 
solid phase extraction represented the first fractionation step of the selected drugs 
Betonica officinalis and Glechoma hederacea, with the aim of separating 
constituents of different polarities, simplifying moreover their subsequent isolation. 
On the basis of their positive results in the pharmacological screening, the 
chlorophyll free dichloromethane extract from Betonica officinalis and the phenol-
free methanol extracts from both plants were subjected to this type of fractionation. 
Bond Elut C18 (10 g) cartridges (Varian, Harbor City, CA, USA) with a reservoir 
volume (RV) of 60 ml were applied on a vacuum box, whose pressure was set at 5.0 
mmHg off. The stationary phase was washed with 5 RV of distilled water and 
methanol, and conditioned with 2 RV of the initial elution concentration of 30% 
MeOH prior to the fractionation.  
Extract amounts between 200 and 350 mg could be applied on the cartridges, 
depending on their solubility in the smallest possible volume of DCM or MeOH 
(approx. 2.0 ml), which has to be evaporated by the vacuum once the extract is 
adsorbed on the stationary phase. After the application of the extracts, the 
cartridges were eluted with a flow rate of about 2 drops per second with aqueous 
solutions of 30%, 70% and 100% MeOH (each 5 RV) in succession, obtaining three 
fractions (A, B and C, respectively) of decreasing polarity. These were taken to 
dryness under reduced pressure and prepared to be subjected to the successive 
chromatografic analyses.  
 
 
2.9  Chromatographic Methods 
 
2.9.1  Gas Chromatography – Mass Spectrometry (GC-MS) 
In order to identify the volatile constituents of the mentioned SPE-fractions, GC-MS 
analyses were carried out using a Shimadzu (Kyoto, Japan) GC-2010 gas 
chromatograph equipped with a Phenomenex Zebron ZB-5 capillary column 
(thickness 0.25 µm, length 60 m, diameter 0.25 mm) and coupled to a quadrupole 
mass selective detector Shimadzu GCMS-QP2010. Data were acquired using a 
Shimadzu GCMSsolution software ver.2.50. 
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Samples were dissolved in methanol or dichloromethane at the concentration of 10 
mg/ml. Injection volume was one microliter, injector temperature was 270 °C and 
detector temperature was 250 °C. Oven temperature program consisted of an initial 
temperature of 50 °C, increased to 270 °C at 3 °C/min and maintained at this level 
for 15 minutes. Carrier gas (Helium 5.0) was used at constant flow mode at 
1.9 ml/min. Electron ionization mass spectra were recorded in the range 40-700 m/z. 
 
 
2.9.2  High Pressure Liquid Chromatography (HPLC) 
A Shimadzu (Kyoto, Japan) HPLC system consisting of a system controller (CBM-
20A), a membrane degasser (DGU-20A5), a solvent delivery unit (LC-20AD), an 
autosampler (SIL-20AC HT), a column oven (CTO-20AC), a photodiode array 
detector (SPD-M20A) and a low temperature light scattering detector (ELSD-LT,    
40 °C) was used for all measurements. Data were acquired using a Shimadzu 
LCsolution software ver.1.25. Methanol and acetonitrile (chromatographic grade) 
were purchased from Merck (Darmstadt, Germany). Water was distilled by an IKA-
Dest M3000 automatic water distillation apparatus (IKA, Staufen, Germany) and 
adjusted to pH 3.0 with concentrated formic acid (Carl Roth, Karlsruhe, Germany) in 
all measurements.  
Phytochemical samples were dissolved in MeOH at the concentration of 5 mg/ml 
when analyzed with analytical columns, or at the concentration of 25 mg/ml if 
semipreparative columns were used. 
In Table 4 are listed the fractions from Betonica officinalis and Glechoma hederacea 
selected to be fractionated by HPLC, as consequence of their activity in the 
pharmacological tests. The experimental parameters used for each fraction are 
listed in the following Table 5. The sample B2C (isolated peak from B2) was 
subjected to a further purification, as it resulted to be a mixture of two compounds. 
Each HPLC run was preceded by an equilibration time of 10 minutes with the initial 
mobile phase composition at the defined temperature, and followed by 10 minutes 
purge time with an elution of 100% MeOH or 95% MeCN. 
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Table 4:  Samples fractionated by HPLC 
Plant species Sample Preparation 
B1 DCM extract - 30% SPE fraction 
B2 DCM extract - 70% SPE fraction Betonica officinalis 
B2C Fraction from B2 
G1 MeOH extract - 30% SPE fraction 
G2 MeOH extract - 70% SPE fraction 
G3 MeOH extract - 100% SPE fraction 
G4 
MeOH extract – polyphenols removed 
(Kottas Pharma) 
G5 
MeOH extract - polyphenols removed 
(Laab im Walde) 
G2D Fraction from G2 
Glechoma hederacea 
G2E Fraction from G2 
 
 
Table 5:  HPLC parameters 
Sample Stationary Phase Mobile Phase (v/v) 
Flow 
Rate 
(ml/min)
Injection 
Volume 
(µl) 
Oven 
Temperature 
(°C) 
B1 
LiChrospher 100 
RP-18, 250 x 4, 5 µm 
Water (A) and Methanol 
(B), 5-100% of B in 60 min 1.0 10 25 
B2 
Aquasil C18 
250 x 4.6, 5 µm 
Water (A) and Acetonitrile 
(B), 40-48% of B in 25 min, 
48-95% of B in 10 min 
1.0 10 15 
B2C 
Luna C18 
250 x 4, 5 µm 
Water (A) and Acetonitrile 
(B), 44-46% of B in 15 min 1.0 10 16 
G1 
LiChrospher 100 
RP-18, 250 x 4, 5 µm 
Water (A) and Methanol 
(B), 5-100% of B in 60 min 1.0 10 25 
G2 
LiChroCART RP-18e 
250 x 10, 5 µm 
Water (A) and Methanol 
(B), 50-100% of B in 90 min 3.0 100 25 
G3 
LiChrospher RP-18 
250 x 4, 5 µm 
Water (A) and Methanol 
(B), 85-100% of B in 45 min 1.0 10 15 
G4 
G5 
Atlantis T3 
150 x 3, 3 µm 
Water (A) and Acetonitrile 
(B), 2-32% of B in 75 min 0.7 10 25 
G2D 
Atlantis T3 
150 x 3, 3 µm 
Water (A) and Acetonitrile 
(B), 40-55% of B in 45 min 0.5 10 25 
G2E 
Atlantis T3 
150 x 3, 3 µm 
Water (A) and Acetonitrile 
(B), 50-65% of B in 60 min 0.5 10 25 
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2.9.3  High Pressure Liquid Chromatography – Mass Spectrometry (HPLC-MS) 
HPLC-MS measurements were carried out in cooperation with Dr. Martin Zehl, 
Department of Pharmacognosy, University of Vienna. The analyses were performed 
on an UltiMate 3000 RSLC-series system (Dionex, Germering, Germany) coupled to 
a 3D quadrupole ion trap mass spectrometer equipped with an orthogonal 
electrospray ionization (ESI) source (HCT, Bruker Daltonics, Bremen, Germany). 
The eluent flow was split roughly 1:8 before the ESI ion source, which was operated 
as follows: capillary voltage: 4.0 or 3.7 kV, nebulizer 30 psi (N2), dry gas flow 8 
L/min (N2) and dry temperature 340 °C or 350 °C. Positive and negative ion mode 
multistage mass spectra (at least MS3) were obtained in automated data-dependent 
acquisition (DDA) mode. Helium was used as collision gas, the isolation window was 
4 Th, and the fragmentation amplitude was set to 1.0 V. All measurements were 
performed with the conditions (mobile/stationary phase, gradient elution, flow rate, 
injection volume, oven temperature) already listed in Table 5. 
 
 
2.10  High Resolution Mass Spectrometry (HRMS) 
HRMS measurements were performed by Dr. Martin Zehl, in cooperation with 
Jürgen König and Martina Köberl, Department of Nutritional Sciences, University of 
Vienna. Spectra of isolated compounds were recorded on an ESI-Qq-TOF mass 
spectrometer (micrOTOF-Q II, Bruker Daltonics, Bremen, Germany) in negative ion 
mode. The sum formula was determined using the SmartFormula algorithm based 
on the mass accuracy and True Isotope Pattern analysis. Additional off-line negative 
ion mode ESI-MSn spectra of these compounds were obtained on the HCT 
instrument using direct infusion. 
 
 
2.11  NMR Spectroscopy 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance  
500 MHz NMR spectrometer using CDCl3 [δ(1H) = 7.26 ppm and δ(13C) = 77.00 
ppm] or CD3OD [δ(1H) = 3.31 ppm and δ(13C) = 49.00 ppm] as solvent. The 
experiments were performed in cooperation with ao. Univ.-Prof. Mag. Dr. Ernst 
Urban, Department of Medicinal Chemistry, University of Vienna. 
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2.12  Biological Testing 
 
2.12.1  PPAR-α / -γ Activation and NF-κB Inhibition 
PPARs and NF-κB assays were carried out in cooperation with Dr. Atanas G. 
Atanasov, Department of Pharmacognosy, University of Vienna. In both cases, 
phytochemical samples were tested in at least three independent experiments. 
Human Embryonic Kidney, HEK293 cells were seeded in 10 cm dishes. After 24 
hours, the cells were transiently transfected with the calcium phosphate precipitation 
method with 10 µg DNA including PPAR-α or -γ expression plasmids, PPAR 
luciferase reporter construct pPPRE-tk3x-Luc and green fluorescent protein plasmid. 
After 6 hours, the cells were transferred in 96 well plates and the medium was 
replaced with a DMEM supplemented with 5% charcoal stripped FBS. Cells were 
subsequently incubated for 18 hours with the indicated concentration of extracts / 
compounds. GW7647 at 50 nM and troglitazone at 5 µM were used as positive 
controls for PPAR-α and –γ, respectively.  
In the NF-κB inhibition assay, the same type of cells, stably transfected with the 
pNFκB-luc (293/NFκB-luc cells, Panomics, RC0014) and seeded in 10 cm dishes, 
were transiently transfected with green fluorescent protein plasmid. Six hours later, 
cells were transferred in 96 well plates and incubated with serum-free DMEM. After 
24 hours, cells were treated with the indicated concentration of extracts / 
compounds and stimulated with 2 ng/ml human recombinant TNF-α for 6 hours. The 
known NF-κB inhibitor parthenolide (PTL) was used as positive control at the 
concentration of 5 µM. 
In both PPARs and NF-κB assays, cells were finally lysed and the luciferase activity 
was quantified on a GeniosPro plate reader (Tecan, Austria) and normalized with 
the green fluorescence level to account for differences in the cell number and / or 
transfection efficiency. 
 
 
2.12.2  TNF-α / LPS-induced E-selectin and IL-8 Downregulation 
The experiments on E-selectin and IL-8 downregulation were performed together 
with Judit Mihaly-Bison and Priv.-Doz. Mag. Dr. Valery Bochkov, Department of 
Vascular Biology and Thrombosis Research, Medical University of Vienna. 
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Plant components were tested in a characteristic inflammatory reaction, where the 
endothelium is activated by inflammatory cytokine (TNF-α) or bacterial product 
(LPS). In a first phase, the downregulation of E-selectin and IL-8 was evaluated at 
the mRNA level, through isolation of RNA from the treated cells and quantification of 
the genes of interest by normalization to a housekeeping gene β2-microglobulin.  
In a second time, ELISA experiments were additionally performed to assess the 
effect of the candidates at the protein level. This further step was carried out in order 
to confirm at the post-transcriptional level the activities observed through the RNA 
isolation. This confers more reliability to the study, as the expression of a certain 
protein is not always closely related to the relative mRNA transcript level. 
 
2.12.2.1  E-selectin and IL-8 mRNA 
For the first phase, TERT technology (hTERT) immortalized human vascular 
endothelial cells (HUVECtert) (Chang et al, 2005) were grown in M199 medium 
(Sigma-Aldrich, St. Luis, MO) containing 20% fetal bovine serum (Sigma, 
Taufkirchen, Germany), endothelial cell growth supplement (Technoclone, Austria) 
and antibiotics. Experiments were performed in triplicates using 12 well plates 
(NUNC, Roskilde, Denmark) in M199 medium supplemented with 3% fetal bovine 
serum and 1% bovine serum albumin (Applichem, Darmstadt, Germany). 
Monolayers of subconfluent quiescent cells were treated for 10 minutes with the 
indicated concentration of extracts / compounds and stimulated with 100 ng/ml of 
TNF-α (PeproTech, Rocky Hill, NJ) or LPS (Sigma-Aldrich, St. Luis MO) for 30 
minutes or 4 hours, respectively. RNA was extracted from the cells using QIAzol 
lysis reagent (Qiagen, Hilden, Germany) and 900 ng thereof were reverse 
transcribed with MulV-RT using Oligo d(T) primers (Applied Biosystems, Carlsbad, 
CA). The relative expression of the genes of interest was determined by Q-PCR 
(Roche, Basel, Switzerland).  
Primers were designed with a PRIMER3 software from the Whitehead Institute for 
Biomedical Research (Cambridge, MA) using the reference mRNA sequences of 
respective genes from the GeneBank (http://www.ncbi.nlm.nih.gov). For IL-8 primers 
5’-ctcttggcagccttcctgatt-3’ (forward) and 5’-tatgcactgacatctaagttctttagca-3’ (reverse), 
for E-selectin 5’-ggtttggtgaggtctgctc-3’ (forward) and 5’-tgatctgtcccggaactgc-3’ 
(reverse) were used. Relative quantification of the investigated genes was 
performed by normalization to a housekeeping gene β2-microglobulin using the 
 27
Material and Methods 
 
mathematical model by Pfaffl (Kadl et al, 2002) and presented as fold variation over 
the control.  
Due to the high number of extracts, the first screening experiments were conducted 
on pools of 10 crude plant extracts at the concentration of 100 µg/ml (each extract 
10 µg/ml, results not shown). Only extracts composing active pools were individually 
evaluated in a second screening phase, at the concentration of 10 µg/ml.  
 
 
2.12.2.2  E-selectin and IL-8 ELISA 
Immortalized human umbilical vein endothelial cells (HUVECtert) (Chang et al, 
2005) were grown in M199 containing 20% FBS, 1% PSF (penicillin, streptomycin, 
fungicide), 1% glutamine and 0,4 % ECGS/H (Endothelial Cell Growth Supplement / 
Heparin; PromoCell, Cat. No. C-30140). Confluent HUVEC-Tert cells were seeded 
into 96 well plates and incubated overnight for attachment of cells (~ 16 hours). 
Phytochemical samples were diluted to their appropriate end concentration in M199 
containing 1% PSF and 2% FBS. TNF-α (PeproTech, Cat. No. 300-01A) and LPS 
(Sigma Aldrich, Cat. No. L2880-25mg) were directly diluted with the samples, to a 
concentration of 200 ng/ml, which is twice the desired end concentration of agonists. 
BAY 11-7082 was used as positive control at the concentration of 5 µM. 
Experiments were performed in six replicates, using 6 adjacent horizontal wells on 
the 96-well plate. The medium was removed from each replicate row and 50 µl of 
diluted samples were added in their appropriate end concentration.  
Samples were incubated for 30 minutes, allowing them to take effect on their cellular 
targets. 50 µl of 2-fold concentrations of agonists (diluted in media containing a 
certain sample, as described) were added to the replicate rows containing the same 
sample in which also the agonist was diluted. Cells were then incubated for 6 hours. 
Detection of secreted IL-8 directly from the medium was performed using the human 
CXCL8/IL-8 ELISA DuoSet ELISA Development kit (R&D Systems, Cat. No. DY208) 
and the TMB 2-Component Microwell Peroxidase Substrate Kit (VWR International, 
Cat. No. 50-76-00). ELISA was performed in 96 well NUNC plates for immune 
reactions (NUNC; F8 MAXISORP, Cat. No. 468667). 
After treatment of the NUNC plates with coating antibody, the culture medium of the 
stimulated cells was applied on the NUNC ELISA plates in a manner that within one 
replicate, 50 µl of two wells were pooled to one well of the NUNC ELISA plate, 
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meaning that six identical treated biological replicates became three analytical 
replicates. The medium containing secreted IL-8 from stimulated cells was 
incubated overnight with the capturing antibody and then removed. Washing steps 
were carried out five times with 100 µl of PBST (0,05% Tween 20). Detection 
antibody and streptavidin (coupled to HRP) were subsequently applied.  
Concerning the E-selectin experiments, the medium was thoroughly removed from 
the stimulated cells. The cells were fixed with freshly diluted 0.1% glutaraldehyde 
(Merck, New Jersey, US; # 1.04239.0250) for 15 minutes at 4 °C and then washed 
with 100 µl of PBST (0,05% Tween 20). Washing steps were carried out 2 times. In 
all steps liquids were removed using a vacuum pump with 8 tips. The dish was 
blocked by incubation with PBS containing 1% BSA (Albumin – Fraktion V; 
AppliChem, Darmstadt, D) for one hour at 37 °C. All subsequent dilutions were 
carried out in PBS containing 0.1% BSA (same supplier). Human E-selectin/CD62E 
MAb (Clone BBIG-E4), Mouse IgG1 (R&D Systems, Minneapolis, US; # BBA16) 
was diluted to a concentration of 0.3 µg/ml and used as primary antibody to detect 
membrane – bound E-selectin. The cells were incubated with primary antibody for 
one hour at 37 °C and washed twice. HRP-conjugated sheep anti-mouse IgG 
polyclonal antibody (CE-Healthcare, Little Chalfont Buckinghamshire, UK; # 
NA931V) was diluted 1:1500 and used as secondary antibody. Cells were incubated 
with secondary antibody at 37 °C for one hour and washed twice. 
In both IL-8 and E-selectin experiments, turnover of substrate for HRP was 
performed according to the instructions manual of the TMB 2-Component Microwell 
Peroxidase Substrate Kit (VWR International). Quantification of IL-8 and E-selectin 
was carried out measuring the optical density (OD) using a SynergyHT Multi-
Detection Microplate Reader (BioTek Instruments, Winooski, VT) at 450 nm, using 
620 nm wavelenght as reference. 
 
 
2.12.3  Statistical analysis 
Statistical analysis of the data was performed with the Prism 4.03 software 
(GraphPad Software Inc., La Jolla, CA). The experimental data are presented as 
means ± standard error of the mean (SEM) from at least three independent 
experiments.  
Statistical significance was determined by ANOVA using Bonferroni post hoc test. P 
values < 0.05 were considered significant  (* P<0.05, ** P<0.01, *** P<0.001). 
Results 
 
 
3  Results 
 
3.1  Biological Screening 
The results of the screening performed on the selected 35 drugs are listed in Table 
6 (legend see Table 7). The phenol-free MeOH extract from G. hederacea, originally 
excluded from E-selectin / IL-8 testing as the crude extract composed an inactive 
pool, was added later due to the strong activity exhibited on PPARs and NF-κB. 
That extract was selected for further investigations together with the extracts from 
Betonica officinalis, which were able to strongly downregulate E-selectin and IL-8. 
 
Table 6:  Pharmacological screening of crude and purified extracts. All samples were tested at 
10 µg/ml. Extracts with no E-selectin / IL-8 available results are intended as not active, as part of 
inactive pools. 
Sample                                              Results 
TNF-α-induced LPS-induced 
Species Plant Part Extract 
PPAR-α 
activation 
PPAR-γ 
activation
NF-κB 
inhibition E-selectin IL-8 E-selectin IL-8 
Agropyron 
repens 
Rhizomes 
DCM 
MeOH 
wP 
strong 
no 
no 
strong 
no 
moderate 
no 
no 
no 
strong 
moderate 
- 
moderate 
moderate 
- 
moderate 
no 
- 
strong 
moderate 
- 
Ajuga 
genevensis 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
- 
strong 
- 
moderate 
- 
no 
- 
no 
- 
strong 
- 
moderate 
- 
no 
- 
Ajuga reptans Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
- 
strong 
- 
moderate 
- 
no 
- 
no 
- 
strong 
- 
moderate 
- 
no 
- 
Alnus viridis Leaves 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
moderate 
no 
no 
no 
moderate 
moderate 
strong 
no 
strong 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Bellis perennis Flowers 
DCM 
MeOH 
wP 
strong 
no 
moderate 
moderate 
no 
moderate 
moderate 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Berberis 
vulgaris 
Fruits 
DCM 
MeOH 
wP 
no 
no 
moderate 
no 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Beta vulgaris Roots 
DCM 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Betonica 
officinalis 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
strong 
strong 
moderate 
strong 
strong 
strong 
strong 
strong 
weak 
strong 
moderate 
weak 
strong 
strong 
strong 
strong 
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Calluna 
vulgaris 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
moderate 
moderate 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Capsella 
bursa-pastoris 
Herb 
DCM 
wCh 
MeOH 
wP 
strong 
strong 
no 
strong 
no 
moderate 
no 
strong 
strong 
no 
no 
strong 
strong 
- 
moderate 
- 
weak 
- 
moderate 
- 
moderate 
- 
no 
- 
strong 
- 
strong 
- 
Equisetum 
arvense 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
moderate 
no 
no 
no 
moderate 
no 
no 
strong 
moderate 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Equisetum 
palustre 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
moderate 
no 
no 
no 
- 
strong 
- 
no 
- 
no 
- 
no 
- 
moderate 
- 
moderate 
- 
no 
- 
Gentiana 
punctata 
Leaves 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Gentiana 
punctata 
Roots 
DCM 
MeOH 
wP 
no 
no 
moderate 
no 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Glechoma 
hederacea 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
strong 
no 
moderate 
no 
strong 
no 
moderate 
no 
strong 
- 
- 
- 
strong 
- 
- 
- 
strong 
- 
- 
- 
no 
- 
- 
- 
no 
Hippophae 
rhamnoides 
Fruits 
DCM 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Hypericum 
maculata 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
moderate 
no 
moderate 
moderate 
no 
no 
no 
moderate 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Linum 
usitatissimum 
Seeds 
DCM 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Lycopodium 
sp. 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
moderate 
no 
no 
no 
moderate 
strong 
strong 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Majorana 
hortensis 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
strong 
no 
no 
no 
moderate 
no 
strong 
no 
moderate 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Melissa 
officinalis 
Leaves 
DCM 
wCh 
MeOH 
wP 
no 
strong 
no 
no 
no 
strong 
no 
no 
moderate 
moderate 
no 
strong 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
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Origanum 
vulgare 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
moderate 
no 
no 
no 
no 
moderate 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Petasites 
hybridus 
Leaves 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
moderate 
strong 
- 
no 
- 
moderate 
- 
strong 
- 
moderate 
- 
no 
- 
moderate 
- 
moderate 
- 
Picea abies Shoot tips 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
moderate 
no 
no 
no 
no 
- 
weak 
- 
no 
- 
no 
- 
no 
- 
no 
- 
no 
-- 
no 
- 
Prunella 
vulgaris 
Herb 
DCM 
wCh 
MeOH 
wP 
no 
moderate 
no 
no 
no 
moderate 
no 
no 
no 
strong 
no 
no 
strong 
- 
strong 
- 
no 
- 
no 
- 
no 
- 
moderate 
- 
no 
- 
no 
- 
Salvia 
officinalis 
Leaves 
DCM 
wCh 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
strong 
strong 
no 
strong 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Sambucus 
ebulus 
Fruits 
DCM 
MeOH 
wP 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
strong 
- 
weak 
strong 
- 
moderate 
weak 
- 
no 
moderate 
- 
Sambucus 
nigra 
Flowers 
DCM 
MeOH 
wP 
no 
no 
strong 
no 
no 
moderate 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Sambucus 
nigra 
Fruits 
DCM 
MeOH 
wP 
no 
no 
strong 
no 
no 
strong 
no 
no 
strong 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Symphytum 
officinale 
Leaves 
DCM 
wCh 
MeOH 
wP 
no 
moderate 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
moderate 
- 
strong 
- 
no 
- 
no 
- 
strong 
- 
no 
- 
strong 
- 
strong 
- 
Symphytum 
officinale 
Roots 
DCM 
MeOH 
wP 
moderate 
no 
no 
moderate 
no 
no 
no 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Symphytum 
officinale 
Stems 
DCM 
wCh 
MeOH 
wP 
no 
strong 
no 
strong 
no 
moderate 
no 
moderate 
no 
no 
no 
no 
moderate 
- 
no 
- 
no 
- 
no 
- 
strong 
- 
no 
- 
strong 
- 
no 
- 
Tussilago 
farfara 
Leaves 
DCM 
wCh 
MeOH 
wP 
moderate 
strong 
no 
moderate 
no 
moderate 
no 
moderate 
moderate 
moderate 
no 
no 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Vaccinium 
myrtillus 
Fruits 
DCM 
MeOH 
wP 
moderate 
no 
moderate 
moderate 
no 
moderate 
no 
no 
no 
no 
strong 
- 
no 
weak 
- 
no 
strong 
- 
moderate 
weak 
- 
Vaccinum 
vitis-idea 
Fruits 
DCM 
MeOH 
wP 
no 
no 
moderate 
no 
no 
strong 
no 
no 
moderate 
no 
no 
- 
no 
strong 
- 
no 
moderate 
- 
weak 
no 
- 
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Table 7:  Results legend 
Activity PPAR-α and -γ NF-κB E-selectin / IL-8 
strong > 2 fold activation above the control > 80% inhibition > 75% inhibition 
moderate 50-100% activation above the control 50-80% inhibition 50-75% inhibition 
weak - - 25-50% inhibition 
no < 50% activation above the control < 50% inhibition < 25% inhibition 
 
DCM Crude dichloromethane extract 
wCh Dichloromethane extract without chlorophyll 
MeOH Crude methanol extract 
wP Methanol extract without polyphenols 
 
 
 
3.2  Phytochemical Analyses 
 
3.2.1  Purification and Solid Phase Extraction 
Chlorophyll and polyphenols eliminations, performed respectively on crude DCM 
and MeOH extracts, resulted on average in low yields, as the removal of other 
constituents is also to be expected. On the other hand, considering only PPARs and 
NF-κB assays (where both crude and purified extract were screened, see Table 6), 
the activity of extracts without chlorophyll or polyphenols was higher in 57 cases, 
while only in 6 cases the purification processes resulted in a decreased biological 
activity.  
The purification yields for the selected plants Betonica officinalis and Glechoma 
hederacea, relative to the crude extracts, are listed in Table 8. 
 
Table 8:  Chlorophyll and polyphenols removal yields (w/w) 
Plant species Plant part 
After chlorophyll 
removal 
(yield %) 
After polyphenols 
removal 
(yield %) 
Betonica officinalis 15.9 3.5 
Glechoma hederacea 
Herb 
12.5 8.1 
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The effectivity of the chlorophyll removal could be verified by 
thin layer chromatography, using Merck silica gel 60 F254 
plates (8 cm development) as stationary phase and a mixture 
of toluol, ethylformiat and concentrated formic acid (5+4+1) as 
mobile phase. Detection was performed at 366 nm. The TLC 
chromatograms in Fig. 11 show the successful separation of 
the chlorophyll (red zone at front) from the DCM extract of 
Folium Malvae. 
 
Figure 11:  TLC chromatograms of Malva DCM extract before (Left) and 
after (Right) the chlorophyll removal 
 
As purified extracts were more active than crude extracts, the successive solid 
phase extraction was performed with them. The results of this first fractionation step 
for the two selected plants are listed in Table 9 (wCh = without chlorophyll; wP = 
without polyphenols). 
 
Table 9:  Solid phase extraction yields (w/w) 
Species Extract Fraction Preparation Yield % 
B1 30% MeOH 47.8 
B2 70% MeOH 23.6 DCM wCh 
B3 100% MeOH 17.1 
B4 30% MeOH 12.4 
B5 70% MeOH 26.8 
Betonica officinalis 
MeOH wP 
B6 100% MeOH 51.9 
G1 30% MeOH 13.8 
G2 70% MeOH 21.1 Glechoma hederacea MeOH wP 
G3 100% MeOH 47.1 
 
 
Once pharmacological evaluated (results in chapter 3.3), the above listed SPE 
fractions B1, B2, G1, G2 and G3 were selected to be further fractionated by HPLC, 
in order to identify and isolate their active constituents. Despite their activity, 
fractions B3, B5 and B6 were excluded from further investigations, as preliminary 
HPLC-MS analyses demonstrated their high relative content of DEHP (also found in 
G3, see pag. 42) or closely related structures. 
 34
Results 
 
3.2.2  Chromatographic Separation and Structure Elucidation 
 
3.2.2.1  Betonica officinalis 
The HPLC-ELSD chromatogram of the fraction B1 (Fig. 12) showed the presence of 
a main component (B1A, Rt: 21.5), which was tentatively identified by LC-MS, 
yielding an [M + Na]+ ion at m/z 429.1 in positive ion mode and an [M - H]- ion at m/z 
405.1 in negative ion mode LC-MS (MW = 406).  
The MSn spectra indicated the presence of an acetyl- and a hexosyl-group, which 
pointed towards the known constituent 8-O-acetylharpagide (Kobzar, 1986; Jeker et 
al, 1989) (Fig. 13).  
Its isolation by HPLC was carried out avoiding heat and acidified water, as these 
factors are known to cause iridoids degradation. Once isolated in sufficient amount 
(3.79 mg), the compound was subjected to 1D and 2D NMR analyses and its 
chemical structure could be confirmed. 
 
Figure 12:  HPLC-ELSD chromatogram of B1 
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Figure 13:  Chemical formula of 8-O-acetylharpagide (B1A) 
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Six other substances could also be detected by LC-MS as trace components of the 
fraction (Fig. 14), however they were not isolated and further processed due to their 
low relative amount. They were tentatively identified as the already known 
compounds allobetonicoside (B1B), 6-O-acetylmioporoside (B1C), reptoside (B1D), 
ajugoside (B1E), martynoside and one isomer of it (B1F and B1G). 
 
Figure 14:  Chemical formulae of the minor components identified in B1 
           
 
C DB E 
GF
 
The HPLC-ELSD fractionation of B2 (Fig. 15) consented the isolation of four 
compounds (B2A, B2B, B2D, B2E) and one mixture of two substances (B2C). The 
further fractionation of B2C (Fig. 16) yielded the pure compound B2C1, which 
represented the major part of the mixture according to the ELSD detection. With 
regard to NMR structure elucidation and biological testing, amounts between 2.64 
and 5.45 mg of the pure compounds were isolated by HPLC. 
In the LC-MS analysis, compounds B2A and B2B were both detected as [M - H]- 
ions at m/z 347.1 and yielded nearly identical fragment ion spectra, dominated by 
consecutive neutral loss of two molecules of CO2, which could, however, not be 
matched to known constituents of Betonica officinalis. HRMS of the isolated pure 
compounds showed the [M - H]- ions at m/z 347.1858 (B2A) and m/z 347.1844 
(B2B), matching to a molecular formula of C20H28O5 (calcd. m/z 347.1864 for 
C20H27O5-). 
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Compound B2C1 yielded an [M + H]+ ion at m/z 345.1 in positive ion mode and an 
[M - H]- ion at m/z 343.1 in negative ion mode LC-MS. The on-line UV spectrum, 
with λmax at 274 nm and 342 nm, and the fragmentation of the [M - H]- ion, which 
showed consecutive neutral loss of three methyl radicals (CH3•), indicated that B2C1 
is a trimethoxy-dihydroxyflavone. Compound B2C1 was finally identified as 
eupatorin, a known constituent of Stachys swainsonii (Skaltsa et al, 2007), by 
comparison of UV spectra (Fig. 17) and HPLC retention times with a commercial 
reference compound.   
HRMS of the isolated pure compound B2D showed the [M - H]- ion at m/z 361.2029, 
matching to a molecular formula of C21H30O5 (calcd. m/z 361.2020 for C21H29O5-). 
Fragmentation in MS2 yielded, among others, the neutral loss of a methyl radical 
(CH3•). Further fragmentation of the resulting fragment ion at m/z 346.1 gave an MS3 
spectrum that closely resembled the MS2 spectra of compounds B2A and B2B, 
suggesting that compound B2D is an O-methylated derivative of compound B2A or 
B2B.  
Compound B2E yielded an [M + H]+ ion at m/z 329.1 in positive ion mode LC-MS. 
The fragmentation pattern and the on-line UV spectrum, which showed λmax at 276 
nm and 329 nm, indicated that B2E could be salvigenin, a known constituent of 
Stachys swainsonii and Stachys ionica (Skaltsa et al, 2007; Meremeti et al, 2004). 
 
Figure 15:  HPLC-ELSD chromatogram of B2 
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Figure 16:  HPLC-UV (Left) and -ELSD (Right) chromatograms of B2C 
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Figure 17:  UV spectra of B2C1 (Left) and commercial eupatorin (Right) 
200 250 300 350 nm
0
25
50
75
100
125
150
175
200
225
mAU
23
7
26
1
29
8
21
3
34
2
27
4
24
2
200 250 300 350 nm
-25
0
25
50
75
100
125
150
175
200
225
250
275
mAU
24
8
23
6
26
2
29
8
21
2
34
2
27
4
24
2
25
2
 
 
Extensive 1D and 2D NMR experiments on the isolated pure compounds finally 
permitted to conclude the structure elucidation. Thus, the five structures from B2 
were determined as follows (Fig. 18): 16-hydroxycleroda-3,13-dien-16,15-olide-18-
oic acid (B2A); 15-hydroxycleroda-3,13-dien-16,15-olide-18-oic acid (B2B); 
eupatorin (B2C1); 15-hydroxycleroda-3,13-dien-16,15-olide-18-oic acid methyl ester 
(B2D); salvigenin (B2E). 
 
 
Figure 18:  Chemical formulae of the compounds isolated from B2 
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3.2.2.2  Glechoma hederacea 
GC-MS and HPLC-MS analyses of G1 permitted to identify for the first time in this 
plant the cyclic hydroxamic acid 2-benzoxazolinone (Fig. 19), as the main 
component of the fraction according to the ELSD detection. 
First, its identification was consented by GC-MS analyses (Fig. 20) with a similarity 
index of 92% (G1A, Rt: 40.4 min). Additionally, 2(4H)-benzofuranone and eicosanoic 
acid methyl ester were found to be present in a much lower amount with a 91% 
similarity index. The HPLC-ELSD and -UV (270 nm) chromatograms of the same 
fraction (Fig. 21) proved that the presence of a main component (G1A, Rt: 23.5 min) 
was not limited to the volatile constituents. The UV spectrum of G1A and its HPLC 
retention time were found to match with the ones of the commercial reference 
compound 2-benzoxazolinone (Fig. 22). Subsequently, HPLC-MS analyses were 
performed using the same conditions as above, in order to gain a further 
confirmation of its identity. As expected, the obtained mass spectrum of G1A was 
found to be according to the one acquired by GC-MS (data not shown). 
The isolation of the compound by HPLC (2,49 mg) was followed by extensive 1D 
and 2D NMR experiments, which confirmed its identity as 2-benzoxazolinone. 
 
Figure 19:  Chemical formula of 2-benzoxazolinone from G1 
 
 
Figure 20:  GC-MS chromatogram of G1 
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Figure 21:  HPLC-UV (Left) and -ELSD (Right) chromatograms of G1 
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Figure 22:  UV spectra of G1A (Left) and commercial 2-benzoxazolinone (Right) 
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The semipreparative HPLC fractionation of G2 yielded seven subfractions, which 
were generated as shown in Fig. 23, as this complex mixture of compounds could 
not be analytically processed. The collected subfractions were pharmacologically 
evaluated and all of them were found to be active on the usual targets (results see 
Table 12, pag. 54). Several HPLC analyses followed by LC-MS measurements 
consented to identify the main component of G2D as the flavonoid acacetin (G2D1, 
Rt: 15.7), while the triterpene esculentic acid (G2E1, Rt: 10.9) was identified in G2E 
(Figs. 24 and 25). Their chemical formulae are shown in Fig. 26. 
 
Figure 23:  HPLC-ELSD chromatogram of G2 
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Figure 24:  HPLC-UV (340 nm) chromatogram of G2D 
 
 
 
Figure 25:  HPLC-ELSD chromatogram of G2E 
 
 
Figure 26:  Chemical formulae of acacetin from G2D (Left) and esculentic acid (Right) from G2E 
       
 
 
The HPLC-ELSD chromatogram of G3 is shown in Fig. 27. This analytical 
fractionation consented to isolate and pharmacologically evaluate three fractions 
and five pure compounds, whose tentative structure elucidation was performed by 
HPLC-MS.  
The major components of this fraction were not considered of particular interest, as 
they were identified as chlorophyll catabolites. Compound G3F was identified as 
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phaeophorbide A (Fig. 28), which derives from the chlorophyll degradation (via 
chlorophyllide) by the enzyme chlorophyllase (Schelbert et al, 2009), while 
compounds G3B, G3E, G3H and fraction G3G were found to be closely related 
structures.  
Compound G3D was found to be diethylhexylphthalate (DEHP), which is a 
commonly used plastic softener and, therefore, does not belong to the plant. The 
presence of this compound in the fraction is due to contamination of the solvents 
used for the extraction, as extensive HPLC and GC-MS analyses demostrated (data 
not shown). 
 
Figure 27:  HPLC-ELSD chromatogram of G3 
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Figure 28:  Chemical formula of phaeophorbide A from G3 
 
 
The chromatographic comparison between the phenol-free MeOH extracts of 
Glechoma hederacea from two different locations (G4 and G5) is shown in Fig. 29, 
through the overlapping of their HPLC-UV chromatograms. 
Whereas several peaks, even if in different relative amounts, were found to be 
common to both samples, the most relevant difference regarded the main 
components of the two extracts.  
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The already mentioned 2-benzoxazolinone, identified as compound G4B (Rt: 31.8), 
could not be detected in G5, where the main component was found to be compound 
G5A (Rt: 71.9). HPLC-MS analyses and the comparison with a commercial 
reference compound consented to identify G5A as the flavonoid apigenin (Fig. 30), 
which could be also detected in G4, although in a much lower amount.  
Further investigations on a higher number of plant samples are required in order to 
explain the absence of 2-benzoxazolinone in G5. 
 
Figure 29:  HPLC-UV (254 nm) chromatograms of G4 and G5 
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Figure 30:  Chemical formula of apigenin from G5 
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3.2.3  HPLC Method Optimization 
The HPLC fractionation of B2 from Betonica officinalis required an extensive method 
optimization, in order to achieve a satisfying separation of its main constituents. 
Several stationary phases were tested with different solvent systems at different 
oven temperatures, before the final method could be chosen. Flow rate and injection 
volume were always 1.0 ml/min and 10 µl, respectively. Representative of the 
optimization process are the four methods which follow. 
In the first one a LiChrospher RP-18 column (250 x 4 mm, 5 µm) was used, with a 
linear gradient from 5% to 100% MeOH in 60 min (v/v) and the oven temperature set 
at 25 °C. The HPLC-ELSD chromatogram showed the presence of one main 
component (Fig. 31).  
In the second method, where acetonitrile was used instead of methanol, the splitting 
of the main peak was observed, evidencing the presence of at least two main 
components (Fig. 32).  
 
Figure 31: HPLC-ELSD chromatogram of B2 (LiChrospher RP-18, 5-100% MeOH in 60 min, 25°C) 
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Figure 32: HPLC-ELSD chromatogram of B2 (LiChrospher RP-18, 5-100% MeCN in 60 min, 25°C) 
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The switch to an Aquasil C18 column (250 x 4.6 mm, 5 µm) in the third method, with 
a flat acetonitrile gradient (40-60% MeCN in 60 min, v/v), resulted in the separation 
of the two main peaks (A, B) but also in the co-elution of other constituents (C) with 
the second one (Fig. 33).  
 
Figure 33: HPLC-ELSD chromatogram of B2 (Aquasil C18, 40-60% MeCN in 60 min, 25°C) 
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The decisive factor in the last method was the oven temperature set at 15 °C 
instead of 25 °C, as the initial acetonitrile gradient (40-48% MeCN in 25 min, v/v) 
was in line with the previous one. 
Besides the good separation of the peaks A, B and C, two further prominent peaks 
(D, E) were observed in the purge step (48-95% MeCN in 10 min, 95% MeCN for 10 
min, v/v) and could also be object of investigation (Fig. 34). The improvement in the 
last run can be distinctly appreciated with three different wavelenghts in Fig. 35. 
 
Figure 34: HPLC-ELSD chromatogram of B2 (Aquasil C18, 40-48% MeCN in 25 min, 15°C) 
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Figure 35: HPLC-UV chromatograms of B2 
(Left: 40-60% MeCN in 60 min, 25 °C; Right: 40-48% MeCN in 25 min, 15 °C) 
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The separation of the two compounds composing B2C was also achieved after 
different trials. Different MeCN gradients (40-48% in 25 min; 41.5-43.5% in 15 min; 
41.5-43.5% in 30 min, v/v) with a flow rate of 0.5 or 1.0 ml/min using a Luna C18 
column (250 x 4 mm, 5 µm) at 15 °C resulted to be not suitable for the purpose.  
A good separation was finally achieved using an extremely slow gradient (44-46% 
MeCN in 15 min, v/v) with a flow rate of 1.0 ml/min and the oven temperature set at 
16 °C (Fig. 16, pag. 37). 
 
 
3.2.4  Further GC-MS analyses 
Besides of the described 2-benzoxazolinone, several other compounds (mainly fatty 
acids and essential oil components) were identified by GC-MS in the SPE fractions 
of Betonica officinalis and Glechoma hederacea.  
MS spectra of the structures listed in Table 10 were found to match those stored in a 
library with a similarity index (SI) value of at least 90%. Fractions B4, B5, B6 and G2 
were found to not contain significant amounts of volatile constituents. 
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Table 10:  Compounds identified by GC-MS in fractions of B. officinalis and G. hederacea 
Fraction Compound 
Limonene dioxide 
4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- 3-Buten-2-ol 
Loliolide 
B1 
cis-Z-α-Bisabolene epoxide 
5,6,7,7a-tetrahydro-4,4,7a-trimethyl-2(4H)-benzofuranone  
Caryophyllene oxide 
Oplopanone 
B2 
Thujopsan-2α-ol 
6,10,14-trimethyl-2-pentadecanone 
6,10-dimethyl-2-undecanone 
Palmitic acid 
Nonadecanol 
Eicosanoic acid, methyl ester 
Hexadecanoic acid 
Octadecanoic acid, methyl ester 
Hexanoic acid, 2-tetradecyl ester 
Stigmasta-4,7,22-trien-3β-ol 
B3 
Stigmasta-5,22-dien-3-ol, acetate 
2-benzoxazolinone 
3-hydroxymethyl-2-benzoxazolinone 
(1S,4R)-p-mentha-2,8-diene 
4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-ol 
4-tridecen-6-yne 
Eicosanoic acid, methyl ester 
Heptacosanoic acid, methyl ester 
G1 
Octadecanoic acid, methyl ester 
Tetradecanal 
Methyl dodecanoate 
6-octadecenoic acid, methyl ester 
5,8-octadecadienoic acid, methyl ester 
Methyl linoleate 
G3 
12-methyltetradecanoic acid, methyl ester 
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3.3  Biological Testing 
 
The pharmacological results of the SPE fractions obtained from the extracts of 
Betonica officinalis and Glechoma hederacea, tested in the different assays at the 
concentration of 10 µg/ml, are listed in Table 11 (legend see Tab. 7, pag. 33). 
In the following graphs, bars represent mean values, error bars consider SEM, stars 
indicate significance compared to TNF or LPS (* P<0.05, ** P<0.01, *** P<0.001). 
 
 
Table 11:  Pharmacological results of the SPE fractions from Betonica officinalis  
and Glechoma hederacea, tested at 10 µg/ml (legend see Tab. 7) 
 
Sample Results 
TNF-α-induced LPS-induced 
Species Extract Fraction PPAR-α PPAR-γ NF-κB 
E-select. IL-8 E-select. IL-8 
B1 - - - moderate moderate weak no 
B2 - - - moderate weak strong moder. 
DCM 
wCh 
B3 - - - no no strong strong 
B4 - - - no no moderate no 
B5 - - - no no strong strong 
Betonica 
officinalis 
MeOH 
wP 
B6 - - - moderate no strong strong 
G1 no no no strong strong no no 
G2 strong strong strong strong strong no no Glechoma 
hederacea 
MeOH 
wP 
G3 moderate moderate strong strong weak no no 
 
 
3.3.1  Betonica officinalis 
8-O-acetylharpagide (B1A), main component of B1, was pharmacologically 
evaluated at different concentrations showing significant activities on TNF-α-induced 
IL-8 and E-selectin at the mRNA level, similarly to the original fraction B1 at           
10 µg/ml. B1A was found to strongly and dose-independently inhibit the TNF-α-
induced IL-8 (Fig. 36), as well as TNF-α-induced E-selectin in a dose-dependent 
manner between 1.0 and 5.0 µg/ml (Fig. 37), while its activity at 10 µg/ml was lower 
in both cases probably due to a toxic effect.  
In contrast, 8-O-acetylharpagide was inactive on these targets at the protein level. 
Furthermore, the closely related iridoids harpagide and harpagoside, even if not 
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identified in Betonica officinalis, were also tested for comparison reasons on the 
same targets with negative results (data not shown). 
 
Figure 36:  Effect of 8-O-acetylharpagide (B1A) on TNF-α-induced IL-8 mRNA 
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Figure 37:  Effect of 8-O-acetylharpagide (B1A) on TNF-α-induced E-selectin mRNA 
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The testing of the fraction B2 at the mRNA level revealed strong downregulations of 
IL-8 and E-selectin at the concentration of 10 µg/ml, particularly of the LPS-induced 
E-selectin, which was inhibited until the basal level.  
Some of the substances isolated from this fraction exhibited significant activities on 
both targets at the concentration of 10 µg/ml (Figs. 38-41). Compound B2C1 
(eupatorin) was able to strongly inhibit the LPS-induced expression of E-selectin and 
IL-8, while the close related flavonoid salvigenin (B2E) was only moderate active on 
LPS-induced E-selectin. Concerning the clerodane diterpenes (B2A, B2B and B2D), 
which were differently active, compound B2B showed the strongest activity on LPS-
induced E-selectin, with a mean inhibition of 96.7%. 
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Figure 38:  Effect of compounds from B2 at 10 μg/ml on TNF-α-induced IL-8 mRNA 
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Figure 39:  Effect of compounds from B2 at 10 μg/ml on LPS-induced IL-8 mRNA 
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Figure 40:  Effect of compounds from B2 at 10 μg/ml on TNF-α-induced E-selectin mRNA 
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Figure 41:  Effect of compounds from B2 at 10 μg/ml on LPS-induced E-selectin mRNA 
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The above described compounds were subsequently evaluated on the TNF-α- and 
LPS-induced IL-8 and E-selectin expression at the protein level by ELISA, with 
different results. Furthermore, the accomplished structure elucidation consented to 
obtain more reliable results through the testing at micromolar concentrations.  
Whereas the original fraction B2, tested at 10 µg/ml, determined an almost complete 
inhibition of both targets (data not shown), the clerodane diterpenes B2A and B2B 
were found to be active at the concentration of 30 µM, particularly on the E-selectin 
expression (Figs. 44 and 45), while B2B could also significantly inhibit the TNF-α-
induced IL-8 expression (Fig. 42). Much weaker but significant activities were 
observed for eupatorin (B2C1) and salvigenin (B2E), while the esterificated 
clerodane diterpene (B2D) was inactive (Figs. 42-45). 
 
Figure 42:  Effect of compounds from B2 at 30 μM on TNF-α-induced IL-8 ELISA 
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Figure 43:  Effect of compounds from B2 at 30 μM on LPS-induced IL-8 ELISA 
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Figure 44:  Effect of compounds from B2 at 30 μM on TNF-α-induced E-selectin ELISA 
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Figure 45:  Effect of compounds from B2 at 30 μM on LPS-induced E-selectin ELISA 
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The subsequent testing of the above descibed compounds on the TNF-α-induced 
NF-κB activation, at the concentration of 30 µM, revealed a moderate inhibition by 
compounds B2A and B2E, while only the flavonoid eupatorin (B2C1) showed a 
significant inhibitory activity (Fig. 46). 
 
Figure 46:  Effect of compounds from B2 at 30 μM on the TNF-α-induced NF-κB activation 
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3.3.1.1  Structure-activity relationships 
On the basis of these results, structure-activity relationships could be delineated 
between the clerodane diterpenes (B2A, B2B, B2D) and the flavonoids (B2C1, 
B2E). It seems to be that the lacton conformation of B2A decreases the activity, 
compared with the one of B2B. Further, the esterification of B2D determines a 
complete loss of activity in comparison with B2B. On the other hand, the alternative 
lacton conformation and the carboxylic function of B2B increase strongly the activity 
(Fig. 47).  
Concerning the flavonoids B2C1 and B2E, which only differ for the hydroxyl group in 
the 3’-position of the first one, different activities were observed especially at the 
mRNA level in LPS-stimulated cells. That hydroxyl function seems to be critical for 
the strong activity of B2C1 (Fig. 48). 
However, further investigations are necessary in order to confirm these assumptions  
and to identify the pharmacophore of these structures. 
 
Figure 47:  Structure-activity relationships between the clerodane diterpenes from B2 
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Figure 48:  Structure-activity relationships between the flavonoids from B2 
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3.3.2  Glechoma hederacea 
Tested at 10 µg/ml, the main component of G1 2-benzoxazolinone (G1A) was able 
to significantly inhibit the TNF-α- and LPS-induced expression of IL-8 and E-selectin 
(Fig. 49). However, this results were not reproducible at the protein level, where 
G1A was only weakly active on LPS-induced IL-8 (data not shown). 
 
Figure 49:  Effect of G1A at 10 μg/ml on  
TNF-α- and LPS-induced IL-8 (A-B) and E-selectin (C-D) mRNA  
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The results of the seven fractions from G2, isolated by semipreparative HPLC and 
tested at the concentration of 10 µg/ml, are listed in Table 12 (legend see Tab. 7). 
All fractions showed strong activity on TNF-α- and LPS-induced E-selectin at the 
mRNA level, five of them also on PPARs activation.  
Similar results were obtained with the fractions generated from G3 (Tab. 13). 
Diethylhexylphthalate (G3D) and phaeophorbide A (G3F) were also able to almost 
completely inhibit the TNF-α-induced NF-κB activation at 10 µg/ml. Phaeophorbide 
A was already found in Isatis tinctoria (Mohn et al, 2009) and in Solanum dislorum, 
where it was also active on NF-κB in PMA-induced HeLa cells (Heinrich, 2003). 
 
Table 12:  Pharmacological results of the fractions from G2 tested at 10 μg/ml 
TNF-α-induced LPS-induced 
Fraction PPAR-α PPAR-γ NF-κB 
E-selectin IL-8 E-selectin IL-8 
G2A no no no strong moderate strong moderate 
G2B no no no strong moderate strong weak 
G2C strong strong no strong moderate strong weak 
G2D strong strong no strong moderate strong weak 
G2E strong strong no strong weak strong weak 
G2F strong strong no strong weak strong weak 
G2G strong strong no strong weak strong weak 
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Table 13:  Pharmacological results of the fractions from G3 tested at 10 μg/ml 
TNF-α-induced LPS-induced 
Fraction PPAR-α PPAR-γ NF-κB 
E-selectin IL-8 E-selectin IL-8 
G3A moderate moderate no strong weak strong weak 
G3B moderate moderate no strong weak strong moderate 
G3C moderate moderate no strong moderate strong weak 
G3D no no strong strong moderate strong moderate 
G3E moderate no no strong weak strong moderate 
G3F no no strong strong weak strong strong 
G3G no no no strong weak strong strong 
G3H no no no strong weak strong moderate 
 
 
As the phenol-free MeOH extract G5 (field-collected sample from Laab im Walde) 
was able to downregulate the IL-8 expression, its main component apigenin (G5A, 
see pag. 43) was also object of investigation, as well as the closely related flavonoid 
acacetin (G2D1), identified in the active fraction G2D. 
The two flavonoids were tested at different concentrations on TNF-α- and LPS-
induced IL-8 and E-selectin at the protein level, showing inhibitory activity in a dose 
dependent manner (Figs. 50-57). Subsequently, they were evaluated on TNF-α-
induced NF-κB at the concentration of 10 µg/ml and found to significantly decrease 
its activation until the basal level (Fig. 58). 
 
 
Figure 50:  Effect of G5A (apigenin) on TNF-α-induced IL-8 ELISA 
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Figure 51:  Effect of G5A (apigenin) on TNF-α-induced E-selectin ELISA 
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Figure 52:  Effect of G5A (apigenin) on LPS-induced IL-8 ELISA 
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Figure 53:  Effect of G5A (apigenin) on LPS-induced E-selectin ELISA 
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Figure 54:  Effect of G2D1 (acacetin) on TNF-α-induced IL-8 ELISA 
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Figure 55:  Effect of G2D1 (acacetin) on TNF-α-induced E-selectin ELISA 
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Figure 56:  Effect of G2D1 (acacetin) on LPS-induced IL-8 ELISA 
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Figure 57:  Effect of G2D1 (acacetin) on LPS-induced E-selectin ELISA 
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Figure 58:  Effect of G5A (Left) and G2D1 (Right) at 10 μg/ml on TNF-α-induced NF-κB activation 
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EC50 were calculated with the inhibition values of apigenin and acacetin on TNF-α- 
and LPS-induced IL-8 and E-selectin (Tab. 14). 
 
Table 14:  EC50 of apigenin (G5A) and acacetin (G2D1)  
on TNF-α- and LPS-stimulated IL-8 and E-selectin 
Compound Target Stimulation EC50 (nM) 
EC50  
(95% confidence interval) 
TNF 31744 27767 to 36291 
IL-8 
LPS 18963 16399 to 21928 
TNF 17708 14871 to 21086 
G5A 
E-selectin 
LPS 13581 12243 to 15066 
TNF 13854 11724 to 16372 
IL-8 
LPS 14177 10631 to 18906 
TNF 10968 8902 to 13513 
G2D1 
E-selectin 
LPS 11689 9938 to 13748 
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3.4  In Silico Screening 
83 compounds from 26 plant species (33 fatty acids, 21 triterpenes, 11 triterpene 
acids, 5 alkaloids, 4 phenylpropanes, 3 isoprenoids, 3 alcohols, 1 aldehyde, 1 
flavonoid and 1 steroid) were found to be active in the one and / or in the other in 
silico model (Tab. 15).  
64 structures thereof were predicted to activate the PPAR-γ receptor, 52 the 
Farnesoid X receptor, while 29 were positive in both models. Therefore, these 
compounds can be supposed to possess anti-inflammatory properties.  
Concerning the screened known compounds from Betonica officinalis and 
Glechoma hederacea, 11 structures were active including 7 fatty acids (-esters) and 
the triterpene 3-epi-ursolic acid, which already showed anti-inflammatory activity in 
vivo (Pastorello et al, 2007).  
From the compounds investigated in vitro in this work, only the flavonoids eupatorin 
and salvigenin, identified in Betonica officinalis, were found to be active in the 5-LOX 
model, while the second one (already positive on FXR) was also active in the IKK-2 
model. 
 
 
Table 15:  In silico Hits 
Structure Plant species PPAR-γ FXR 
 
Hexadecanoic acid 
Agropyron repens   
Bellis perennis  
Calluna vulgaris  
Capsella bursa-p. 
Equisetum arvense 
Equisetum palustre 
Hippophae rhamn. 
Linum usitatissim. 
Lycopodium sp.  
Origanum vulgare  
Prunella vulgaris  
Sambucus nigra  
Sambucus ebulus  
Tussilago farfara  
Vaccinium vitis-id. 
+ + 
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Structure Plant species PPAR-γ FXR 
 
Octadecanoic acid 
Agropyron repens  
Bellis perennis  
Calluna vulgaris  
Capsella bursa-p. 
Hippophae rhamn. 
Linum usitatissim. 
Origanum vulgare  
Prunella vulgaris  
Sambucus nigra  
Sambucus ebulus 
+ + 
 
9,12-Octadecadienoic acid (9Z,12Z) 
Bellis perennis 
Equisetum arvense 
Hippophae rhamn. 
Linum usitatissim. 
Sambucus nigra 
Sambucus ebulus 
Tussilago farfara 
+ + 
 
Acetyleugenol 
Melissa officinalis 
 
+ - 
 
9-Octadecenoic acid (9Z)- ethyl ester 
Hippophae rhamn. + + 
 
9,12-Octadecanoic acid (9Z,12Z)- methyl ester 
Bellis perennis  
Betonica officinalis 
Equisetum arvense  
Origanum vulgare 
Sambucus ebulus 
+ + 
 
9-Octadecenoic acid (9Z) 
Agropyron repens 
Hippophae rhamn. 
Prunella vulgaris 
Sambucus nigra 
Sambucus ebulus 
+ + 
 
Docosanoic acid 
Agropyron repens 
Capsella bursa-p. 
Prunella vulgaris 
Sambucus nigra 
+ + 
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Structure Plant species PPAR-γ FXR 
 
1-Octadecanol 
 
Betonica officinalis 
 
- + 
 
Tetradecanoic acid ethyl ester 
Hippophae rhamn. 
 
+ + 
 
Hexadecanoic acid 1-methylethyl ester 
Bellis perennis 
Origanum vulgare 
 
+ + 
 
2-Hexadecen-1-ol, 3,7,11,15-tetramethyl- (2E,7R,11R) 
Bellis perennis 
Equisetum arvense 
Glechoma hed. 
Majorana hortensis 
Origanum vulgare 
Picea abies 
Tussilago farfara 
- + 
 
9,12,15-Octadecatrienoic acid methyl ester (9Z,12Z,15Z) 
Bellis perennis 
Origanum vulgare 
Tussilago farfara 
 
+ + 
 
9-Hexadecenoic acid (9Z) 
Bellis perennis 
Hippophae rhamn. 
Linum usitatissim. 
Sambucus ebulus 
+ + 
 
9,12,15-Octadecatrieonic acid (9Z,12Z,15Z) 
Agropyron repens 
Bellis perennis 
Equisetum arvense 
Hippophae rhamn. 
Linum usitatissim. 
Sambucus nigra 
Sambucus ebulus 
Symphytum off. 
Vaccinium vitis-id. 
+ - 
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Structure Plant species PPAR-γ FXR 
(+)-Berbamunine 
Berberis vulgaris 
 
+ - 
 
1-Hexadecen-3-ol, 3,7,11,15-tetramethyl 
 
Glechoma hed. 
 
- + 
 
Heptadecanoic acid 
Bellis perennis 
Hippophae rhamn. 
 
+ + 
 
6,9,12-Octadecatrienoic acid (6Z,9Z,12Z) 
Hippophae rhamn. 
Symphytum off. 
 
+ + 
 
Eicosanoic acid 
Agropyron repens 
Capsella bursa-p. 
Hippophae rhamn. 
Prunella vulgaris 
Sambucus nigra 
+ - 
 
15-Tetracosenoic acid (15Z) 
Sambucus nigra 
 
+ - 
 
Hexacosanoic acid 
Lycopodium sp. 
Sambucus nigra 
 
+ - 
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Structure Plant species PPAR-γ FXR 
 
Tetradecanoic acid 
Agropyron repens 
Bellis perennis 
Calluna vulgaris 
Capsella bursa-p. 
Hippophae rhamn. 
Linum usitatissim. 
Sambucus ebulus 
Tussilago farfara 
+ - 
 
(+)-Erythrodiol 
Hippophae rhamn. 
Prunella vulgaris 
 
- + 
 
Tetracosanoic acid 
Agropyron repens 
Sambucus nigra 
 
+ - 
 
Hexadecanoic acid ethyl ester 
 
Betonica officinalis 
Hippophae rhamn. 
Prunella vulgaris 
Sambucus ebulus 
Vaccinium myrtillus 
+ + 
 
Tridecanoic acid 
Bellis perennis 
 
+ - 
 
1-Tetradecanol 1-acetate 
Lycopodium sp. 
 
+ + 
 
Sitosteryl acetate 
Equisetum arvense 
 
+ - 
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Structure Plant species PPAR-γ FXR 
 
3-Epi-ursolic acid 
 
Glechoma hed. + + 
 
Pentadecanoic acid 
Sambucus ebulus 
Tussilago farfara 
Bellis perennis + + 
 
Octadecanoic acid 9,10-dihydroxy- methyl ester 
Sambucus nigra 
 
+ + 
 
Oleanolic acid methyl ester 
Prunella vulgaris 
 
- + 
 
6,9-Octadecadienoic acid 
Prunella vulgaris 
 
+ + 
 
Ferulic acid methyl ester 
Lycopodium sp. 
 
+ - 
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Structure Plant species PPAR-γ FXR 
 
2-Heptadecanone 
ambucus ebulus 
 
Bellis perennis 
S
+ + 
 
Acetic acid farnesyl ester 
Origanum vulgare 
 
+ - 
 
Corosolic acid methyl ester 
runella vulgaris 
Sorbus aucuparia 
- + P
 
Corosolic acetate methyl ester 
Prunella vulgaris 
 
- + 
 
Ursa-12,20(30)-dien-28-oic acid 2,3,23-trihydroxy-
(2α,3α,4α) 
Prunella vulgaris 
 
+ - 
 
9-Hydroxy-10,12-octadecadienoic acid 
 
Glechoma hed. 
 
+ + 
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Structure Plant species PPAR-γ FXR 
 
10,12-Octadecadienoic acid 9-hydroxy- (9S,10E,12E)  
 
Glechoma hed. + + 
 
Salvigenin 
Salvia officinalis 
 
- + 
 
Methyl 2α,3β,23-triacetoxyurs-12-en-28-oate 
runella vulgaris 
 
- + P
 
Crategolic acid methyl ester 
Prunella vulgaris 
 
- + 
 
Methyl 3-epimaslinate 
Prunella vulgaris 
 
+ + 
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Structure Plant species PPAR-γ FXR 
 
3-Epimaslinic acid 
Prunella vulgaris 
 
+ + 
 
(±)-Corypalmine 
Berberis vulgaris 
 
- + 
 
(Z,Z)-6,9-Octadecadienoic acid 
Agropyron repens + + 
 
 
 methyl ester 
Bellis perennis 
Betonica officinalis 
Equisetum arvense 
Hippophae rhamn. 
Origanum vulgare 
Tussilago farfara 
s 
+ + 
Hexadecanoic acid,
Vaccinium myrtillu
2,2'-(3-Ethyl-6-sulfobenzothiazolinone) azine 
eta vulgaris 
Hippophae rhamn. 
Melissa officinalis 
 
 
- + B
 
(2Z,6E)-Farnesyl acetate 
Origanum vulgare + - 
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Structure Plant species PPAR-γ FXR 
 
3-Epicorosolic acid 
 Prunella vulgaris
 
+ - 
 
3-Epicorosolic acid methyl ester 
+ + Prunella vulgaris 
 
 
Euscaphic acid 
runella vulgaris 
 
- + P
 
9-Oxo-10,12-octadecadienoic acid 
lechoma hed. 
 
+ + 
 
G
 
Methyl 2α,3α-diacetoxyurs-12-en-28-oate 
Prunella vulgaris 
 
- + 
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Structure Plant species PPAR-γ FXR 
 
Linolenic acid 9-hydroperoxide 
 
Glechoma hed. 
 
+ + 
 
2-Butenoic acid 2-methyl-3,7-dimethyl-2,6-octadienyl ester 
(Z,E) 
Bellis perennis 
 
- + 
 
Urs-12-en-28-oic acid 2,3,23-trihydroxy- methyl ester 
(2α,3α,4β)-(9CI) 
Prunella vulgaris 
 
+ - 
 
Urs-12-en-28-oic acid 2,3,23-trihydroxy (2α,3α,4β)  
Prunella vulgaris + - 
 
(+)-Thaligrisine 
Berberis vulgaris 
 
- + 
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Structure Plant species PPAR-γ FXR 
 
Rosmarinic acid methyl ester 
runella vulgaris 
 
Melissa officinalis 
P
+ - 
 
Olean-12-en-28-oic acid 2,3,23-tris(acetyloxy)- methyl 
ester (2α,3α,4β)-(9CI) 
Prunella vulgaris 
 
- + 
 
Isoarjunolic acid 
Prunella vulgaris 
 
+ - 
 
Olean-12-en-28-oic acid 2,3,2
(2α,3α,4β)-(9CI) 
3-trihydroxy- methyl ester 
Prunella vulgaris 
 
- + 
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Structure Plant species PPAR-γ FXR 
 
Esculentic acid 
Prunella vulgaris 
 
+ - 
 
Ursa-12,20(30)-dien-28-oic acid 2,3-dihydroxy- methyl 
ester (2α,3α)-(9CI) 
Prunella vulgaris + + 
 
 
Oleana-11,13(18)-dien-28-oic acid 2,3,23 rihydroxy- 
Prunella vulgaris + - 
-t
methyl ester (2α,3α,4β)-(9CI) 
 
 
Ursa-12,20(30)-dien-28-oic acid 2,3-bis(acetyloxy)- methyl 
ester (2α,3α)-(9CI) 
Prunella vulgaris - + 
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Structure Plant species PPAR-γ FXR 
 
Oleana-11,13(18)-dien-28-oic acid 2,3,23-trihydroxy-
(2α,3α,4β)-(9CI) 
Prunella vulgaris 
 
+ - 
 
Ursa-12,20(30)-dien-28-oic acid 2,3,23-trihydroxy- methyl 
ester (2α,3α,4β)-(9CI) 
runella vulgaris 
 
- + P
 
(12R,13S)-2α,3α,24-Trihydroxy-12,13-cyclotaraxer-14-en-
28-oic acid 
runella vulgaris 
 
+ - P
 
(12R,13S)-2α,3α,24-Trihydroxy-12,13-cyclotaraxer-14-en-
28-oic acid methyl ester 
a vulgaris 
 
+ - Prunell
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Structure Plant species PPAR-γ FXR 
 
13,27-Cycloolean-11-en-28-oic acid 2,3,23-trihydroxy- 
methyl ester (2α,3α,4β)-(9CI)  
Prunella vulgaris 
 
+ + 
 
13,27-Cycloolean-11-en-28-oic acid 2,3,23-trihydroxy- 
(2α,3α,4β)-(9CI)  
Prunella vulgaris 
 
+ - 
 
Ursa-12,20(30)-dien-28-oic acid 2,3,23-trihydroxy 
(2α,3α,4α) 
Prunella vulgaris + - 
(-)-Tejedine 
Berberis vulgaris 
 
+ + 
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Structure Plant species PPAR-γ FXR 
 
Butyl rosmarinate 
Prunella vulgaris 
 
+ - 
 
3,6,17-Eicosatrienoic acid 
Prunella vulgaris 
 
+ - 
 
(-)-Simulanol 
Berberis vulgaris 
 
+ - 
 
Ursane-3,23-diol (3β,4α) 
Prunella vulgaris 
 
+ - 
 
Ursane-2,3,19-triol (2α,3β) 
Prunella vulgaris 
 
+ - 
 
Ursane-2,3-diol (2α,3β) 
Prunella vulgaris 
 
+ - 
 
Results 
 
3.5  Comparison of Methods for Removal of Bulk Constituents 
from Plant Extracts (Paper) 
The following manuscript, entitled “Elimination of bulk polyphenols and chlorophyll 
from plant extracts influences their in vitro anti-inflamatory activity – the method 
matters”, concerns the chromatographic and pharmacological comparison of 
different extract purification methods. The author of this thesis, together with Mag. 
Sylvia Vogl, was responsible for the phytochemical work indicated with the codes 
CR1 and PR1, as well as for the chromatographic analyses. The manuscript has 
been submitted for publication. 
 
Elimination of bulk polyphenols and chlorophyll from plant extracts 
influences their in vitro anti-inflammatory activity – the method matters 
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Abstract 
Ubiquitous plant constituents, such as chlorophyll and phenolic compounds, can 
interfere with biological in vitro assays. Moreover, these substances represent a 
significant portion of plant extracts, decreasing the relative amount of other bioactive 
components. The aim of this study was to examine (i) whether chlorophylls and 
phenolic compounds from plant extracts may lead to false positive or false negative 
results in three selected cell-based anti-inflammatory test systems, (ii) whether their 
elimination markedly alters the bioactivity of extracts, and (iii) whether there are 
differences between distinct clearance procedures. Three commonly used methods 
to eliminate chlorophyll and phenolic compounds were applied; all of them efficiently 
removed bulk constituents as confirmed by HPLC and mass spectrometry. Plant 
extracts were evaluated before and after removal of chlorophyll and polyphenols for 
their potential to inhibit the activation of the transcription factor NF-κB and the 
expression of interleukin-8 (IL-8), induced by the pro-inflammatory stimuli tumor 
necrosis factor (TNF-α) or lipopolysaccharide (LPS) in human umbilical vein 
endothelial cells. Chlorophyll A and B, tannic acid, epicatechin gallate and 
rosmarinic acid (the latter three as representatives of common polyphenols) were 
also tested in these assays. Obtained results show that depending on the methods 
used, the activity of extracts can be strongly increased by purification, but also 
decreased due to loss of bioactive constituents. As none of the pure compounds 
showed an influence on the selected biological systems, except for a weak activity 
of epicatechin gallate on IL-8, the increase in activity observed after purification of 
extracts in some cases is likely due to an enrichment of the active compounds.  
In summary, bulk compounds removal processes represent a valuable strategy for 
the biological evaluation of plant extracts, but their effectiveness has to be validated 
and a possible loss of active substances has to be considered. 
 
 76
Results 
 
1. Introduction 
Plant-derived natural products represent an important source of new compounds 
effective against various diseases, including disorders associated with inflammation 
(Butler, 2008; Cragg and Newman, 2006; Foster et al., 2005; Harvey, 2007; 
Newman, 2008; Newman and Cragg, 2007). To identify new potential bioactive 
compounds, biological in vitro assays are used (Swinney and Anthony, 2011). When 
testing plant extracts in biological in vitro assays, a potential interference of 
ubiquitous substances, such as chlorophyll and polyphenols, must be considered 
since they may generate false positive or false negative results. Chlorophyll is 
known to interact with fatty acids, whereas tannins can form tight complexes with 
metal ions, proteins and polysaccharides (Potterat and Hamburger, 2006). Relative 
to tannins, most non-polyphenolic compounds appear in much lower amounts in 
polar plant extracts (Silva et al., 1998), while chlorophyll typically represents more 
than a half of crude nonpolar extracts. We therefore hypothesized that the 
elimination of bulk constituents, such as polyphenols and chlorophyll, may result in a 
higher specific bioactivity of plant extracts, which consequently should be purified 
prior to pharmacological evaluation in vitro. 
Three common methods for the removal of chlorophyll and polyphenols, 
respectively, were applied in this study on extracts of two Austrian medicinal plants, 
Folium Malvae ÖAB (Malvaceae) and the aerial parts of Glechoma hederacea L. 
(Lamiaceae), respectively. The plant extracts were evaluated for their ability to 
inhibit TNF-α-induced NF-κB transactivation activity and the TNF-α- and LPS-
induced interleukin-8 expression. Since the interference of chlorophyll and 
polyphenols with these specific assays was unclear, we tested effects of pure 
chlorophyll A, chlorophyll B, tannic acid, epicatechin gallate and also rosmarinic 
acid, which is known to be present in Glechoma hederacea (Okuda et al., 1986). 
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2. Materials and Methods 
2.1. Plant material 
The dried leaves of Malva ssp. (Folium Malvae according to the Austrian 
Pharmacopoeia, ÖAB) and the dried aerial parts of Glechoma hederacea (each 2 
kg) were obtained from Kottas Pharma GmbH (Vienna, Austria), authenticated by 
Prof. Johannes Saukel and finely grinded before extraction. Voucher specimens 
(Mal-le-08_1 and Gle-hb-08_1, respectively) are deposited at the Department of 
Pharmacognosy, University of Vienna, Austria. 
 
2.2. Reagents and Chemicals 
Methanol, dichloromethane and acetonitrile were HPLC-grade (VWR, Vienna, 
Austria). Formic acid was purchased from Carl Roth (Karlsruhe, Germany). 
Chlorophyll A and B (both of 95% purity) and tannic acid were purchased from Fluka 
Chemical Corp. (Ronkonkoma, NY, USA). Epicatechin gallate (98% purity) was 
purchased from Sigma Aldrich (Steinheim, Germany), while rosmarinic acid (98% 
purity) was obtained from Extrasynthese (Genay, France). 
 
2.3. Extraction 
The extraction was performed using two different methods. Method A: 3.0 g grinded 
material of the two model plants were extracted first with DCM and after drying with 
MeOH, using an accelerated solvent extractor ASE200 (Dionex Corp., Sunnyvale, 
CA, USA) equipped with 22 mL stainless steel extraction cells and 60 mL glass 
collection bottles. The extraction conditions were the following: 3 extraction cycles, 5 
min heat-up time, 2 min static time, 10% flush volume, 60 sec nitrogen purge, 40 °C 
oven temperature and 150 bar pressure.  
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Method B: 3.0 g plant material was extracted three times with 30 mL of DCM, 
respectively, in an ultrasonic bath for 15 min at room temperature; the solvent was 
evaporated under reduced pressure. The remaining plant material was extracted 
three times with MeOH using the same procedure.  
Subsequently, DCM extracts from Malva were used for the chlorophyll elimination 
comparison, while MeOH extracts from Glechoma hederacea were subjected to the 
different polyphenols elimination procedures. The extraction yields are listed in 
Table 1. 
 
2.4. Chlorophyll elimination 
The first of three chlorophyll elimination methods (CR1), applied on the DCM 
extracts of Malva, was based on a liquid-liquid partition between DCM and a mixture 
of MeOH/H2O. The extract (extraction method A) was dissolved in a defined volume 
of DCM (6.67 mg/mL) and the same amount of MeOH/H2O 1:1 was added. 
Dichloromethane was removed under reduced pressure and chlorophyll, which 
precipitated in methanol/water, was filtered. 
For the second method (CR2), preparative TLC plates (20x20 cm, silica gel 60, 
Merck) were pre-developed in DCM until the solvent front reached the end of the 
plate, in order to remove impurities. Next, the extract (extraction method A) was 
loaded onto the plate respecting a distance of 1 cm from the edges. Then the plate 
was developed in DCM until the solvent front progressed 16 cm from the starting 
line. Subsequently the plate was air dried and developed a second time utilizing a 
solvent mixture of 80% DCM and 20% EtOAc. The process was stopped once the 
solvent front had reached the upper border of the chlorophyll band minimizing the 
size of the latter. The entire silica gel, except areas containing chlorophyll and 
previously removed impurities (17-20 cm), was scratched from the plate and 
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sonicated in DCM and consecutively in MeOH. The obtained solution was finally 
filtered and dried under reduced pressure. 
For the third method (CR3), the extract (extraction method B) was fractionated using 
column chromatography (Lichroprep RP18, 3.0 x 25 cm), and eluted with mixtures of 
MeOH and MeCN (300 + 0 mL, 150 + 50 mL, 50 + 50 mL, 25 + 75 mL, 0 + 150 mL) 
yielding two fractions: the MeOH eluate F1 (39.8 mg) and F2 (75.0 mg) by means of 
visual assessment and TLC monitoring (DCM - MeOH, 19:1; detection UV-VIS, 
vanillin-H2SO4). According to TLC, F1 was free from chlorophyll in contrast to the 
eluate F2. 
 
2.5. Elimination of polyphenols 
Three methods to eliminate polyphenols were applied on the MeOH extracts of 
Glechoma hederacea. Method PR1 was based on liquid-liquid partitions between 
CHCl3 and mixtures of MeOH/H2O (Wall et al., 1996). The extract (extraction 
method A) was first dissolved in MeOH/H2O (9:1) and defatted by partition with 
hexane. H2O was added to the aqueous phase generating a solution MeOH/H2O 
3:1, which was partitioned with CHCl3. The organic phase was finally washed with 
1% NaCl, yielding the phenol-free extract. 
Method PR2: 5.0 g of Polyamide SC 6.6 (Macherey and Nagel, Duren, Germany) 
were mixed with distilled water. The suspension was incubated for 24 h before being 
transferred into a column. The column was rinsed with 150 mL MeOH and 
afterwards loaded with 92.4 mg of dissolved extract (extraction method A). Then the 
column was eluted with 250 mL MeOH and the obtained solution was finally dried 
under reduced pressure (Houghton and Raman, 1998). 
Method PR3: The extract (extraction method B) was subjected to column 
chromatography (Polyamide 6S, Riedel DeHaen AG, Seelze, Germany) using a step 
gradient of H2O and MeOH (60 + 0 mL, 30 + 30 mL, 15 + 45 mL, 10 + 50 mL, 0 + 
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350 mL) producing two fractions: circa 250 mL of eluate F1 (79.3 mg) and F2 (4.5 
mg) by means of visual assessment and TLC monitoring (DCM – MeOH, 9:1; 
detection UV-VIS, vanillin-H2SO4). FeCl3 solution (Ph.Eur.) was added to a sample 
of each fraction to assess the presence of phenolic compounds. Fraction F1 was 
considered free of phenolic compounds in the absence of a positive reaction. 
 
2.6. High performance liquid chromatography (HPLC) 
A Shimadzu (Kyoto, Japan) HPLC system consisting of a system controller (CBM-
20A), a membrane degasser (DGU-20A5), a solvent delivery unit (LC-20AD), an 
autosampler (SIL-20AC HT), a column oven (CTO-20AC), a photodiode array 
detector (SPD-M20A) and a low temperature light scattering detector (ELSD-LT, 40 
°C) was used for the measurements. Chromatographic analyses of original and 
purified extracts were carried out on an Atlantis T3 (Waters, Milford, MA, USA) 
analytical column (150 x 3 mm, 3 µm) with an oven temperature of 25 °C. The flow 
rate was 0.7 mL/min and 20 μL sample were injected from a cooled (15 °C) 
autosampler tray. A gradient elution of H2O (A, adjusted to pH 2.8 with formic acid) 
and MeCN (B) was used for Malva extracts (25-55% of B in 60 min, 55-85% of B in 
40 min, v/v), while different conditions (2-32% of B in 75 min, v/v) were applied for 
G. hederacea extracts.  
 
2.7. High performance liquid chromatography – mass spectrometry (HPLC-MS) 
In order to identify the main constituents of the extracts and to prove the successful 
removal of the target substances, HPLC-MS analyses were performed using the 
same conditions as described above. The measurements were performed using an 
UltiMate 3000 RSLC-series system (Dionex, Germering, Germany) coupled to a 3D 
quadrupole ion trap mass spectrometer equipped with an orthogonal electrospray 
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ionization (ESI) source (HCT, Bruker Daltonics, Bremen, Germany). The eluent flow 
was split roughly 1:8 before the ESI ion source, which was operated as follows: 
capillary voltage: 4.0 or 3.7 kV, nebulizer: 30 psi (N2), dry gas flow: 8 L/min (N2), dry 
temperature: 340 °C or 350 °C. Positive and negative ion mode multistage mass 
spectra (at least MS3) were obtained in automated data-dependent acquisition 
(DDA) mode. Helium was used as collision gas, the isolation window was 4 Th and 
the fragmentation amplitude was set to 1.0 V. 
 
2.8. NF-κB transactivation activity 
Human embryonic kidney 293 (HEK-293) cells stably transfected with an NF-κB-
driven luciferase reporter gene (293/NFκB-luc cells, Panomics, RC0014) were 
seeded in 10 cm dishes and transfected with 5 µg pEGFP-C1 (Clontech). Six hours 
later cells were transferred to 96 well plates and incubated at 5% CO2 and 37 °C 
overnight. On the next day the medium was exchanged with a serum-free DMEM 
and the indicated treatments were performed. After 30 min, cells were stimulated 
with 2 ng/mL recombinant human TNF-α for 4 h, then the medium was removed and 
the cells were lysed. Plant extracts as well as reference pure compounds were 
tested at the concentration of 10 µg/mL in at least three independent experiments 
with four replicates each, while parthenolide was used as positive control at the 
concentration of 5 µM. The luminescence of the firefly luciferase and the 
fluorescence of EGFP were quantified on a GeniosPro plate reader (Tecan). The 
luciferase signal derived from the NF-κB reporter was normalized by the EGFP 
derived fluorescence to account for differences in the cell number or transfection 
efficiency.  
 
 
 82
Results 
 
2.9. Interleukin-8 ELISA 
TERT technology (hTERT) immortalized human umbilical vein endothelial cells 
(HUVECtert) (Chang et.al, 2005) were cultured in M199 medium supplemented with 
20% fetal calf serum (both from Sigma-Aldrich, St Louis, MO), cell growth 
supplement (Promocell, Germany) and antibiotics. At least three independent 
experiments with six replicates each were performed in 96 well plates (Iwaki, Japan) 
in M199 medium containing 1% BSA (Applichem, Darmstadt, Germany) and 3% 
serum. Plant extracts were tested at the concentration of 10 µg/mL, reference pure 
compounds at 10 µM, while BAY 11-7082 was used as positive control at the 
concentration of 5 µM. Subconfluent HUVECtert cells were pre-treated for 30 min 
with the plant material or inhibitor as indicated, followed by stimulation with 100 
ng/mL of TNF-α (PeproTech, Rocky Hill, NJ) or 300 ng/mL of LPS (Sigma-Aldrich, 
St. Louis, MO) for 6 h. Secreted IL-8 was determined by ELISA from the cell culture 
supernatants using the Quantikine® Human CXCL8/IL-8 Immunoassay Kit (R&D 
Systems, Minneapolis, MN). Supernatants were transferred into 96 well plates 
(NALGE-NUNC Int., Rochester, NY) coated with capturing antibody for IL-8 and 
developed with the respective detection antibody. Peroxidase activity was assessed 
with TMB 2-Component Microwell Peroxidase Substrate Kit (KPL, Gaithersburg, 
MD), while the optical density (OD) was measured with a SynergyHT Multi-Detection 
Microplate Reader (BioTek Instruments, Winooski, VT) at 450 nm using 620 nm 
wavelength as reference.  
 
2.10. Statistical analysis 
The experimental data are presented as means ± standard error of the mean (SEM) 
from three independent experiments. Statistical significance was determined by 
ANOVA using Bonferroni post hoc test. P values < 0.05 were considered significant 
(* P<0.05, ** P<0.01, *** P<0.001). 
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3. Results and Discussion 
First, effective and fast methods for the elimination of polyphenols and chlorophyll 
from plant extracts were selected. To remove polyphenols, chromatography on 
polyamide using two different elution methods was chosen. Precipitation with 
gelatin/NaCl, polyvinylpyrrolidone (PVP) or caffeine was found to be inadequate, 
since these procedures unspecifically clear compounds with phenolic groups 
including flavonoids, whose removal is not desired. As a third method, we used 
liquid-liquid partition between CHCl3 and mixtures of MeOH/H2O published by Silva 
et al. (1998) and Wall et al. (1996), which is fast and easy to perform. To eliminate 
chlorophyll, we selected solvent partitioning between DCM and MeOH/H2O (Silva et 
al., 1998), column chromatography (RP18), as well as preparative TLC (Sherma and 
Fried, 2004; Silva et al., 1998). 
Fig.1 shows that neither chlorophyll A and B nor the polyphenols tannic acid, 
epicatechin gallate and rosmarinic acid influence the TNF-α-induced NF-κB 
activation at the concentration of 10 µg/mL (1a,1c), while only epicatechin gallate 
weakly inhibits the TNF-α-induced IL-8 expression at 10 µM (1d). Furthermore, they 
did not activate NF-κB or induce IL-8 expression, when applied to unstimulated cells 
(data not shown).  
 
Figure 1: Chlorophyll A (Chl A) and B (Chl B), tannic acid (TA), epicatechin gallate (ECG) and 
rosmarinic acid (RA) do not inhibit NF-κB activation at 10 µg/mL (a,c) and do not interfere, except 
weakly ECG, with IL-8 expression at 10 µM (b,d) in TNF-α-stimulated cells. Positive control (5 µM): 
parthenolide (PTL) or BAY 11-7082 (BAY). Bars represent mean values, error bars consider SEM, 
stars indicate significance compared to TNF: * P<0.05, ** P<0.01, *** P<0.001. 
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Chlorophyll-depleted extracts, tested at 10 µg/mL in TNF-α- or LPS-stimulated cells, 
influenced IL-8 expression or NF-κB activity differently, depending on the used 
depletion method. The crude DCM extract from Malva significantly inhibited NF-κB 
activation and IL-8 expression in TNF-α- and LPS-stimulated cells. All chlorophyll 
clearance methods resulted in a clear loss of activity (Fig. 2).  
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Figure 2: Effects of Malva DCM extracts purified from chlorophyll using methods CR1, CR2 and CR3 
on NF-κB activity in TNF-α-stimulated cells (a) and IL-8 expression in TNF-α- (b) or LPS- (c) stimulated 
cells at 10 µg/mL. Positive control (5 µM): parthenolide (PTL) or BAY 11-7082 (BAY). Bars represent 
mean values, error bars consider SEM, stars indicate significance compared to TNF or LPS: * P<0.05, 
** P<0.01, *** P<0.001. 
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Using different methods to clear extracts from polyphenols, the resulting differences 
are even more pronounced. Method PR1 led to disclosure of a strong NF-κB and IL-
8 inhibitory activity of the Glechoma hederacea methanol extract (Figs. 3a, 3b and 
3c). In contrast, methods PR2 and PR3 resulted in extracts that showed the same 
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inactivity as the crude methanol extract (Figs. 3a and 3b) or led to inactive extracts 
whereas the crude methanol extract showed inhibitory activity at 10 µg/mL (Fig. 3c). 
 
Figure 3: Effects of Glechoma hederacea MeOH extracts purified from polyphenols using methods 
PR1, PR2 and PR3 on NF-κB activity in TNF-α-stimulated cells (a) and IL-8 expression in TNF-α- (b) 
and LPS- (c) stimulated cells at 10 µg/mL. Positive control (5 µM): parthenolide (PTL) or BAY 11-7082 
(BAY). Bars represent mean values, error bars consider SEM, stars indicate significance compared to 
TNF or LPS: * P<0.05, ** P<0.01, *** P<0.001. 
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To explain these differences, the chlorophyll- and polyphenol-depleted extracts were 
analytically evaluated. The yields of the different purification procedures (w/w, 
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relative to the crude extracts), as well as those of the extractions (w/w, relative to the 
drug weight), are listed in Table 1. 
 
Table 1:  Extraction, chlorophyll and polyphenols removal yields (w/w) 
Malva Glechoma hederacea 
DCM extract Chlorophyll  MeOH extract Polyphenols  
(yield) removal (yield) (yield) removal (yield) 
CR1 (11.0%) ) PR1 (8.0%
A (4.0%) 
CR2 (40.0%) 
A (8.5%) 
PR2 (72.0%) 
B (3.8%) B (5.4%) CR3 (34.6%) PR3 (48.6%) 
 
 
yses of the original and purified extracts were performed to verify the 
successful depletion of the target substances, to assess the enrichment of the other 
constituents as well as the unintended loss of non-target compounds. Comparison 
with pure reference compounds as well as LC-MS analyses permitted the 
identification of the substances of interest, demonstrating that chlorophyll and 
polyphenols were effectively removed by all three applied procedures.  
Chlorophyll, identified as peak 4 (Rt: 97 min) in the DCM extract of Malva (Fig. 4), 
was quantitatively removed by all three methods, and this purification process 
resulted in the enrichment of other more polar constituents (methods CR1 and 
CR3). However, the ELSD detection (Fig. 5) demonstrates that peak 1 (Rt: 83.5 
min), identified as linolenic acid and found to be the main component of the extract, 
was also removed, as was peak 2 (Rt: 90.5 min), identified as linoleic acid. In 
contrast, peak 3 (Rt: 96.5 min), which was found to be oleic acid, was saved and 
enriched only with method CR3. This last compound could not be observed in the 
HPLC-UV chromatogram due to the lack of chromophores. 
 
HPLC anal
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F
remo
igure 4: HPLC-UV (254 nm) chromatogram of Malva DCM extracts (CR1, CR2, CR3: chlorophyll 
val methods 1, 2, 3. DCM: crude dichloromethane extract). 
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Figure 5: HPLC-ELSD chromatogram of Malva DCM extracts (CR1, CR2, CR3: chlorophyll remova
ethods 1, 2, 3. DCM: crude dichloromethane extract). 
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HPLC analyses of Glechoma hederacea extracts (Fig. 6) showed the successful 
clearance of rosmarinic acid, which was identified as peak 6 (Rt: 52.5 min), by all 
methods. Furthermore, method PR1 resulted in a strong enrichment of peak 5 (Rt: 
31.8 min). This compound, identified by LC-MS as the cyclic hydroxamic acid 2-
benzoxazolinone, can be supposed to be responsible for the activity of the relative 
phenol-free extract. 
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F
poly
igure 6: HPLC-UV (254 nm) chromatogram of Glechoma hederacea MeOH extracts (PR1, PR2, PR3: 
phenols removal methods 1, 2, 3. MeOH: crude methanol extract). 
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he data suggest that the method selected to remove bulk compounds has a 
olyphenols, aside from a weak IL-8 
move 
T
dramatic influence on the in vitro anti-inflammatory activity of plant extracts. It can 
either enhance the specific activity due to enrichment of active components, or 
result in loss of general anti-inflammatory activity in cell-based in vitro assays due to 
unspecific co-depletion of active constituents.  
Neither chlorophyll A and B nor the tested p
inhibition by epicatechin gallate, interfered with the used cell-based anti-
inflammatory assays. Nevertheless, high amounts of such bulk components in crude 
extracts can mask or dilute the effect of active compounds. On the other hand, 
depletions are not specific and may lead to the loss of bioactive constituents.  
In conclusion, our data clearly show that the selection of a proper method to re
bulk constituents can be a valuable strategy to specifically enrich plant compounds 
influencing inflammatory parameters in vitro. However, a HPLC profiling before and 
after the clearance procedure is recommended, in order to ensure an effective 
elimination of the respective bulk compounds and to detect a possible loss of active 
constituents. 
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Discussion 
 
4  Discussion 
Folk medicine has always played an important role in the finding of new 
pharmaceutical strategies. As traditional knowledges often represented the starting 
point of the medical research, numerous natural products or structures derived 
threof are nowadays employed in the therapy of various diseases. Therefore, the 
scientific proof of claimed beneficial properties of plant extracts and moreover the 
identification of their active principles represent an important challenge.  
The topic of this thesis was the investigation of Austrian medicinal plants traditionally 
used against inflammatory disorders, with the aim of confirming their beneficial 
properties on a scientific basis, revealing their active principles as well. For this 
purpose, a number of drugs were selected to be investigated, exclusively on the 
basis of their traditional anti-inflammatory applications. Besides the selection of the 
candidates, an important factor was the choice of an appropriate fractionation 
strategy, in the path from field-collected or purchased plant materials to the relative 
pure active compounds. 
 
Different factors (e.g. synergism, potentiation, concentration), however, can 
differentiate the biological activity of crude extracts and pure compounds isolated 
thereof.  
In several cases, we could observe stronger anti-inflammatory activities in extracts 
or fractions than in the main substances composing them, which were tested at 
different concentrations. Fraction B2 from Betonica officinalis, for instance, was able 
to strongly downregulate the IL-8 expression at the protein level. As all major 
components of this fractions were isolated and tested, two of them (the clerodane 
diterpenes B2A and B2B) showed a significant activity in the same assay, however 
much lower than that of the original fraction. This indicates that minor undetectable 
components or possibly a synergism between different constituents was responsible 
for part of the activity.  
Moreover, the fact that no one of the isolated pure compounds showed significant 
activation of PPAR-α and -γ, despite even strong activities exhibited by the relative 
extracts or fractions, could be explained by such phenomena. 
 
Furthermore, the possible influence of ubiquitous plant components such as 
chlorophyll and polyphenols, which often represent the main part of crude extracts, 
has to be considered. The testing of these substances demonstrated that none of 
them have pro- or anti-inflammatory activity in the applied in vitro assays. Therefore, 
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the higher activity of the purified extracts observed in most cases is due to 
enrichment of their active constituents.  
In the screening phase of this study, for instance, the phenol-free MeOH extract of 
Sambucus nigra fruits showed strong activity in every used anti-inflammatory in vitro 
assay, in contrast with the original one, which was completely inactive. Similarly, the 
DCM extract of Prunella vulgaris herb acquired strong activity only after the 
chlorophyll removal. 
On the other hand, chromatographic analyses indicated that the applied separation 
methods are not fully selective and they can also result in the loss of the active 
principles. The data suggest that selection of method for removal of bulk 
constituents can have dramatic influence on the anti-inflammatory activity of plant 
extracts. Thus, purification processes represent a valuable strategy for specific 
enrichment of plant compounds regulating inflammation, as first step of the isolation 
process, but their effectiveness should be always proved and the possible co-
depletion of other substances has to be considered. 
These investigations resulted in a relevant overview about pro and contra of 
commonly applied methods for the elimination of bulk components from plant 
extracts (submitted manuscript - chapter 3.5). 
 
A bioactivity guided fractionation represented the ideal approach for the isolation of 
active compounds from the selected plant materials.  
By this meaning, a step-by-step biological testing of extracts and derived fractions of 
different polarities could trace the right way of the research. In order to isolate pure 
compounds from the active fractions, different HPLC-based strategies were 
considered using semipreparative and analytical columns, depending on the 
complexity of the samples, as well as different detection systems. The employment 
of smaller particle size (3 µm) stationary phases resulted in excellent separation 
results, which were followed in some cases by satisfying LC-MS structure 
elucidations, performed also with the support of commercial reference compounds. 
On the other hand, these HPLC columns are characterized by a smaller loading 
capacity and therefore they are not suitable for the isolation of acceptable amounts 
of pure compounds. For this reason, columns with a higher particle size (5 µm) but 
at the same time a lower resolution were used for the isolation, even if this strategy 
required extensive method optimizations (see chapter 3.2.3). The achievement of 
pure compounds in sufficient amount was followed by the NMR structure 
elucidation, as well as by the biological testing. 
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The choice of appropriate molecular targets has also a crucial role in the finding of 
anti-inflammatory properties, as the possibilities are numerous. It is known that the 
nuclear factor κB plays an important role in inflammation, as its translocation into the 
nucleus of endothelial cells determines the transcription of pro-inflammatory genes. 
On the other hand, several factors can activate the NF-κB translocation and they 
represent even valuable targets. In addition to a cell-based NF-κB transactivation 
assay, where its inhibition by the candidates can be directly evaluated, the ability of 
extracts and pure compounds to activate the nuclear receptors PPAR-α and –γ, as 
well as to downregulate the TNF-α- or LPS-induced mediators E-selectin and IL-8 
was also investigated both at the mRNA and at the protein level. 
Hence, the activity of a candidate on the one and / or on the other molecular target 
can give an overview about its mechanism of action. 
 
While IL-8 and E-selectin expression was initially measured at the mRNA level, we 
had in a second time the opportunity to perform these assays at the protein level. 
There is considerable uncertainty regarding the general, genome-wide correlation 
between levels of RNA and corresponding proteins (Gry et al, 2009). Comparing 
RNA and protein profiles of several gene products in different human cell lines, Gry 
et al. found significant correlations in only one third of the examined RNA species 
and corresponding proteins. As post-transcriptional effects are consequence of the 
protein expression, which can be distantly related to the mRNA transcript level, the 
experiments performed by ELISA concerning IL-8 and E-selectin downregulation 
should be considered more reliable than those conducted at the mRNA level. 
 
The first relevant result about the general anti-inflammatory properties of the 
selected plants was achieved with the pharmacological screening, as only 4 of 35 
investigated drugs (Beta vulgaris roots, Gentiana punctata leaves, Hippophae 
rhamnoides fruits, Linum usitatissimum seeds) did not show any activity, while 
several of the 31 other drugs showed strong activities in the applied assays. 
Subsequently and after extensive literature surveys, the herbs of Betonica officinalis 
and Glechoma hederacea were chosen to be deeper investigated, as besides their 
promising results in the mentioned screening, they resulted to be less studied so far. 
Thus, the dried aerial parts of the two plants, which should be responsible for the 
therapeutic properties according to their traditional application, were re-extracted on 
a larger scale, depleted from bulk constituents and further processed. 
 95
Discussion 
 
Whereas the discussed purification processes were useful to enrich the relative 
concentration of the compounds of interest, the successive solid phase extraction 
turn out to be not less important, as it consented to work on more but simpler active 
fractions, instead of complex crude extracts. This first fractionation step permitted 
not only to exclude inactive fractions, but also to simplify the successive 
chromatographic isolation of pure compounds from the active ones. 
 
As mentioned in chapter 3.2.2.1, some of the substances identified in Betonica 
officinalis (e.g. iridoids, flavonoids) are already known to be present in other Stachys 
species. On the other hand, three clerodane diterpenes were identified and isolated 
for the first time in this plant. Compound B2A was previously found in the leaves of 
Echinodorus grandiflorus (Costa et al, 1998), while compound B2B and its methyl 
ester B2D were identified in the aerial parts of Grangea maderaspatana (Krishna 
and Singh, 1999). However, no biological properties were reported for these 
compounds before. An in vivo strong anti-inflammatory activity was recently 
observed in some analogue clerodane diterpenoids from Dodonaea polyandra, 
which were found to be active in a 12-O-tetradecanoylphorbol-13-acetate (TPA)-
induced mouse ear edema model (Simpson et al, 2011). The similarity of the 
diterpenes from B. officinalis with these active structures suggests the possibility to 
evaluate them also in vivo. 
Our investigations indicate the clerodane diterpenes 16-hydroxycleroda-3,13-dien-
16,15-olide-18-oic acid (B2A) and 15-hydroxycleroda-3,13-dien-16,15-olide-18-oic 
acid (B2B), as well as the flavonoid eupatorin, as potential anti-inflammatory agents, 
being able to significantly inhibit of the TNF-α- and/or LPS-induced IL-8 and E-
selectin expression. 
The different activities shown by the compounds B2A and B2B, which differ only for 
the conformation of the lacton, consented to delineate structure-activity relationships 
between them, with a good correlation between mRNA and protein level regarding 
the downregulation of IL-8 and E-selectin. Nevertheless, their activity at the protein 
level was found to be weaker, with moderate but still significant anti-inflammatory 
properties. 
So far, the results indicated the benefit of one lacton conformation than the other, as 
well as the negative effect of the esterification. In order to better delineate the 
pharmacophore of these compounds, further investigations will be performed in 
cooperation with the Department of Vascular Biology and Thrombosis Research, 
Medical University of Vienna. Similar structures should be synthesized starting from 
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commercial available compounds and their anti-inflammatory properties will be step-
by-step evaluated and compared. 
 
The iridoid 8-O-acetylharpagide, which was able to significantly inhibit TNF-α-
induced E-selectin and IL-8 at the mRNA level, represents another interesting 
finding. Already known as constituent of B. officinalis, this compound was already 
found to possess antibacterial, antifungal, antispasmodic, cardiotonic, and also 
antipyretic activity when administered in higher doses (Shafi et al, 2004), while 
moderate anti-inflammatory activity was observed in vivo in a carrageenan induced 
paw edema model (Ahmed et al, 2003). 
 
The bioactivity guided fractionation of Glechoma hederacea consented to identify, 
for the first time in this plant, the cyclic hydroxamic acid 2-benzoxazolinone, which 
showed anti-inflammatory properties on IL-8 and E-selectin at the mRNA level. 
Since the first report on it hypnotic properties (Lespagnol and Lefebvre, 1945), a 
number of derivatives of this compound have been tested for various biological 
activities (Çalış et al, 2001). This substance was previously isolated from Acanthus 
ilicifolius (Kapil et al, 1994) and Calceolaria thyrsiflora (Bravo et al, 2005), and found 
to possess leishmanicidal and antibacterial activity, respectively. 
Interestingly, 2-benzoxazolinone could be detected in only one of two analyzed 
samples of G. hederacea, moreover as its main component. Although it has to be 
considered a natural compound, being already described to be present in other plant 
species, this finding could also indicate a possible contamination of the plant 
material obtained from Kottas Pharma GmbH. Besides the absence of 2-
benzoxazolinone in the field-collected drug (Laab im Walde), it is even significant 
that this compound was never found in this plant species before. Analyses of further 
plant samples should clarify this inconsistency. 
 
The flavonoid acacetin, known as a constituent of Glechoma longituba (Yang et al, 
2006), was previously found to significantly inhibit protein and mRNA expression of 
iNOS and COX-2 in LPS-induced RAW 264.7 macrophages, without toxicity at 
concentrations between 5 and 40 µM (Pan et al, 2006). The same biological 
properties were observed in the close related compound apigenin, which also 
inhibited the NF-κB activation in an analogous test system (Liang et al, 1999). In 
contrast, both flavonoids were found to be inactive on the LPS-induced nitric oxide 
production in J774 macrophages, and toxic at the concentration of 100 µM 
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(Hamalainen et al, 2007). Finally, apigenin was found to inhibit the TNF-α-induced 
IL-8 production in human endothelial cells, but not the NF-κB activation (Gerritsen et 
al, 1995). 
Besides the strong TNF-α-induced NF-kB inhibition, both flavonoids were able in our 
experiments to dose-dependently downregulate IL-8 and E-selectin at the protein 
level, both in TNF-α- and in LPS-stimulated cells. As the transcription of IL-8 and E-
selectin is consequence of the NF-kB translocation into the nucleus, it might be 
assumed that the anti-inflammatory activity of the flavonoids is due to the significant 
limitation of that process. 
 
Although the anti-inflammatory properties of the mentioned flavonoids are already 
described in the literature, they could explain the activity of the respective extracts / 
original fractions and, moreover, represent a scientific confirmation of the traditional 
applications of Glechoma hederacea against inflammatory diseases. Analogously, 
the bioactivity guided fractionation of Betonica officinalis resulted in the finding of 
active compounds and in the identification of three clerodanes diterpenes, which 
were never found in this plant species before.  
However, further investigations including in vivo evaluations should be performed, in 
order to better understand the potential of these promising compounds as anti-
inflammatory agents. 
 
First and foremost, the pharmacological screening performed on 35 medicinal plants 
revealed to be highly significant, as the claimed anti-inflammatory properties of 
almost 90% of the selected drugs could be confirmed on a scientific basis.  
This alone has to be considered a critical finding, as it shines a light on the Austrian 
traditional medicine and represents a step forward for the phytotherapy. 
Summary 
 
5  Summary 
Austrian folk medicine represents an important starting point for the research of new 
active compounds in traditional used plants. Several drugs with claimed anti-
inflammatory activity, in particular, were considered in this study, with the aim of 
identifying their active principles and giving a scientific evidence of their therapeutic 
properties. From the selected candidates, extracts covering a wide range of polarity 
were generated and subjected to depletion of their bulk constituents, i.e. chlorophyll 
and polyphenols from nonpolar and polar extracts, respectively, in order to enrich 
the concentration of the active compounds. 
A large number of extracts with and without bulk constituents was screened using 
different cell-based anti-inflammatory assays. This resulted basically in two 
important results: besides the stronger activity observed in most cases in the 
purified extracts, almost 90% of the tested drugs showed activity in the one or in the 
other assay. Furthermore, a huge number of structures, known to be present in the 
selected plants, were screened in silico on different anti-inflammatory targets, 
revealing several interesting candidates. 
Accomplished the screening, the herbs of Betonica officinalis and Glechoma 
hederacea were selected to be deeper investigated, through a bioactivity guided 
fractionation. Besides their positive results in the in vitro assays, both plants find 
application against inflammatory diseases in the Austrian folk medicine and, 
furthermore, they are less studied so far. The path between plant materials and pure 
compounds isolated thereof was covered through different phytochemical 
techniques, such as extraction, bulk constituents depletion, solid phase extraction, 
GC-MS, semipreparative and analytical HPLC analyses, while the conclusive 
structure elucidation was performed through NMR measurements. 
The bioactivity guided fractionation of the two selected plants resulted in the 
identification by HPLC-MS and GC-MS of 46 compounds, 9 of which could be 
isolated and tested. Three clerodane diterpenes and the cyclic hydroxamic acid 2-
benzoxazolinone were found for the first time in Betonica officinalis and Glechoma 
hederacea, respectively. 
The pharmacological evaluation of the isolated pure compounds in different anti-
inflammatory assays revealed the flavonoids apigenin and acacetin as the most 
active ones, as both were able to strongly downregulate IL-8 and E-selectin 
expression in a dose-dependent manner, as well as to inhibit the NF-κB activation. 
Furthermore, two of the clerodane diterpenes showed significant activities on IL-8 
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and E-selectin at the protein level. Other compounds, such as 2-benzoxazolinone, 
were active on IL-8 and E-selectin at the mRNA level. However, these activities 
were non reproducible at the protein level.  
In conclusion, the present study confirmed the claimed anti-inflammatory properties 
of several Austrian medicinal plants, revealing moreover some of their active 
constituents. 
 
Zusammenfassung 
 
6  Zusammenfassung 
Die österreichische Volksmedizin repräsentiert eine wichtige Quelle für die 
Ermittlung neuer aktiver Substanzen aus traditionell angewandten Heilpflanzen. 
Verschiedene Drogen mit traditionell überlieferten anti-inflammatorischen 
Eigenschaften sind für diese Studie ausgewählt worden, um ihre Wirkprinzipien zu 
ergründen und einen wissenschaftlichen Beweis ihrer therapeutischen Wirksamkeit 
zu gewinnen. 
Polare und unpolare Extrakte sind aus den ausgewählten Drogen hergestellt worden 
und beziehungsweise von Polyphenolen und Chlorophyll befreit worden, um die 
potentiell aktiven Inhaltstoffe anzureichen. Danach wurde eine große Anzahl von 
Extrakten mit und ohne Begleitsubstanzen in verschiedenen anti-inflammatorischen 
zellbasierten Assays gescreent. Dieses Screening ergab zwei Hauptresultate: 
neben der häufig stärkeren Aktivität der gereinigten Extrakte, zeigten nahezu 90% 
der getesteten Drogen Aktivität in dem einen oder anderen Assay. Darüber hinaus 
wurden zahlreiche bekannte Strukturen aus den ausgewählten Pflanzen in silico auf 
verschiedene entzündungshemmenden Targets gescreent, ebenfalls mit 
interessanten Resultaten. 
Auf Grund der Screening-Ergebnissen wurden die oberirdische Pflanzenteile von 
Betonica officinalis und Glechoma hederacea ausgewählt und mit Hilfe einer 
bioaktivität-geleiteten Fraktionierung genauer untersucht. Neben ihren positiven 
Ergebnissen in den in vitro Assays, beide Pflanzen werden in der österreichischen 
Volksmedizin gegen Entzündung verwendet und sind aber bisher wenig untersucht 
worden. 
Um aus dem pflanzlichen Ausgangsmaterial aktive Reinsubstanzen zu isolieren 
wurden verschiedenen phytochemischen Verfahren wie Extraktion, Abtrennung von 
Begleitsubstanzen, Festphasen-Extraktion, GC-MS, semipräparative und 
analytische HPLC Analysen durchgeführt. Die endgültige Strukturaufklärung erfolgte 
mittels NMR Spektroskopie. 
46 Substanzen sind durch die bioaktivität-geleitete Fraktionierung der zwei 
ausgewählten Pflanzen identifiziert worden, 9 davon konnten isoliert und getestet 
werden. Drei Clerodan Diterpene und die zyklische Hydroxamsäure 2-
benzoxazolinone sind zum ersten Mal in Betonica officinalis beziehungsweise in 
Glechoma hederacea nachgewiesen worden. 
Die pharmakologische Evaluierung der isolierten Reinsubstanzen in verschiedenen 
Assays ermittelte die Flavonoide Apigenin und Acacetin als die aktivsten, da beide 
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eine relevante dosisabhängige Herunterregulation von IL-8 und E-selectin zeigten, 
sowie eine starke Inhibierung des Transkriptionsfaktors NF-κB. Darüber hinaus 
zeigten zwei der Clerodane Diterpene eine signifikante Aktivität auf IL-8 und E-
selectin auf der mRNA-Ebene als auch auf Proteinebene, während die starke 
Wirkung von 2-benzoxazolinone auf mRNA-Ebene beschränkt war. 
Zusammenfassend bestätigt die vorliegende Studie die behaupteten anti-
inflammatorische Eigenschaften von mehreren österreichischen Heilpflanzen, und 
konnte zusätzlich einige ihrer aktiven Inhaltstoffe aufklären. 
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8  List of Abbreviations 
 
 
AP1 Activator protein-1 IKK-2 IκB kinase-2 
ASE Accelerated solvent extraction IL-8 Interleukin-8 
BSA Bovine serum albumin iNOS Inducible nitric oxide synthase 
COX Cyclooxygenase LC-MS Liquid chromatography mass spectrometry 
DCM Dichloromethane 5-LOX 5-lipoxygenase 
DDA Data-dependent acquisition LPS Lipopolysaccharide 
DEHP Diethylhexylphthalate NF-κB Nuclear factor κB 
DPPH 2,2-diphenyl-1-picrylhydrazyl NMR Nuclear magnetic resonance 
ECGS/H Endothelial Cell Growth Supplement/Heparin OD Optical density 
EGFP Enhanced green fluorescent protein PBS Phosphate buffer solution 
ELISA Enzyme-linked immunosorbent assay PBST Phosphate-buffered saline Tween 
ELSD Evaporative light scattering detector PMA phorbol 12-myristate 13-acetate 
ESI Electrospray ionization PPAR Peroxisome proliferator activated receptor 
FBS Fetal bovine serum PTL Parthenolide 
FRAP Ferric reducing ability of plasma PVP Polyvinylpyrrolidone 
FXR Farnesoid X receptor q-PCR Quantitative polymerase chain reaction 
GC-MS Gas chromatography mass spectrometry Rt Retention time 
HCT High capacity ion trap SEM Standard error of the mean 
HEK293 Human embryonic kidney 293 SI Similarity index 
HPLC High performance liquid chromatography SPE Solid phase extraction 
HRMS High resolution mass spectrometry TLC Thin layer chromatography 
HRP Horseradish peroxidase TMB 3,3,5,5-tetramethylbenzidine 
HUVEC Human umbilical vein endothelial cells TNF Tumor necrosis factor 
ICAM Intracellular adhesion molecule-1 ESI-TOF Electrospray-Quadrupole-Time-of-Flight 
IFN-γ Interferon-γ wCh Without chlorophyll 
IkB-α Inhibitor κB-α wP Without polyphenols 
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57th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural 
Product Research. August 16th – 20th, 2009 – Geneva, Switzerland. 
 
Poster presentation 
 
Screening of 35 plants used in Austrian folk medicine for PPAR-α and -γ 
activation and NFkB inhibition 
 
Paolo Picker, Sylvia Vogl, Nanang Fakhrudin, Atanas Atanasov, Elke Heiß, Gottfried 
Reznicek, Johannes Saukel, Christoph Wawrosch, Verena M. Dirsch, Brigitte Kopp. 
 
Department of Pharmacognosy, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria 
 
Austria and its adjacent regions have a great history in traditional folk medicine. 
Folk-medicinal knowledge was collected over years and transferred to the 
VOLKSMED database [1] which contains an exact botanical description of each 
used plant. The aim of this study was to investigate the potential in vitro anti-
inflammatory activity of plants selected from that database, using luciferase reporter 
gene assays. 
Thirty five preselected plants were extracted with dichloromethane (DCM) and 
methanol (MeOH) using the Accelerated Solvent Extractor (Dionex ASE200). The 
chlorophyll, if present, was separated from the DCM extract, whereas the tannins 
were removed from the MeOH extract, in order to avoid possible interferences with 
the assay formats [2]. Crude and purified extracts were then examined for activation 
of PPAR-α and -γ and inhibition of NFκB using HEK293 cells transfected with green 
fluorescence protein plasmid (as internal control). The cells were also accordingly 
transfected with PPAR-α or -γ plasmids and reporter plasmid pPPRE-tk3x-Luc in the 
PPAR assay, while a pNFκB-luc transfection and a TNF-α stimulation were used in 
the NF-kB assay. Luciferase activity and fluorescence intensity were then measured 
using a GeniosPro plate reader. 
The extracts of fifteen plants showed no activity in the applied assays, while the 
other twenty exhibited activity in one or more of the test systems. The three most 
active ones in both assays were the DCM extract with the chlorophyll separated of 
Urtica dioica leaves, the MeOH extract with the tannin separated of Sambucus nigra 
fruits and the DCM extract with the chlorophyll separated of Prunella vulgaris herb. 
 
Acknowledgements: This work is funded by the Austrian Science Fund FWF: S10704-B037 
 
References: 1.Saukel J (2006) Sci. Pharm. 74:36.  2.Potterat O and Hamburger M (2006) Curr. Org. 
Chem. 10:899-920 
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58th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural 
Product Research. August 29th – September 2nd, 2010 – Berlin, Germany. 
 
Short lecture 
 
Bioactivity-guided isolation of potential anti-inflammatory constituents from 
Betonica officinalis 
 
Picker P1, Mihaly-Bison J2, Vogl S1, Zehl M1, Urban E3, Reznicek G1, Saukel J1, 
Wawrosch C1, Binder BR2, Kopp B1 
 
1Department of Pharmacognosy, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria 
2Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, 
Schwarzspanierstrasse 17, A-1090 Vienna, Austria 
3Department for Medicinal Chemistry, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria 
 
Betonica officinalis (Lamiaceae) has been used in Austrian traditional medicine 
since ancient times against inflammatory disorders. The aim of this study was to 
investigate the anti-inflammatory properties of extracts, derived fractions, and 
isolated pure compounds of this plant by assessment of their effect on genes (E-
selectin, IL-8) that are induced by inflammatory stimuli (TNF-α or LPS) in endothelial 
cells [1,2]. 
The plant material (herb) was extracted with dichloromethane (DCM) using an 
accelerated solvent extractor. Chlorophyll was separated by liquid-liquid-partition 
between DCM and a mixture of MeOH-H2O 1:1, in order to increase the 
concentration of the active compounds. Since the purified DCM extract showed 
strong activity in the mentioned assay, a bioactivity-guided fractionation was carried 
out. Subfractions were obtained by solid-phase extraction using C18 cartridges 
eluted with 30%, 70%, and 100% MeOH. The 30% and the 70% subfractions, which 
showed highest activity, were further fractionated by HPLC in order to identify and 
investigate their active constituents, whose structures were elucidated by HPLC-MS, 
1D, and 2D NMR spectroscopy. 
Besides of some known polymethylated flavonoids (e.g. salvigenin), particularly the 
iridoid 8-O-acetylharpagide and two new diterpenoids were found to inhibit between 
46% and 99% the LPS-stimulated induction of E-selectin at the concentration of 10 
µg/ml, evidencing a considerable potential as new anti-inflammatory agents. 
 
Acknowledgements: This work is funded by the Austrian Science Fund, NFN: S10704-B037 
 
References: 1. Chang et al. (2005) Exp Cell Res. 309(1):121-36; 2. Kadl et al. (2002) Vascul 
Pharmacol. 38(4):219-27. 
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